Armando Rogerio Martins Teixeira-Pinto

CONTACTINFORMATION

School of Public Health, Faculty of Medicine and HealthEdward Ford Building (A27), Office 226A Voice: (61) 2 93515424THE UNIVERSITY OF SYDNEY Fax: (61) 2 93515109NSW 2006, Australia E-mail: armando.teixeira-pinto@sydney.edu.au

EDUCATION Harvard University, Graduate School of Arts and Science, Boston, USA Jun 2007Ph.D. in Biostatistics

• Dissertation Topic: “Multivariate analysis of non-commensurate outcomes”• Advisor: Sharon-Lise T. Normand

Harvard University, Harvard School of Public Health, Boston, USA Jun 2004A.M. in Biostatistics

University of Porto, Faculty of Medicine, Porto, PortugalProvas de aptidao pedagogica e capacidade cientıfica (equivalent to a Master), Dec 2000

• Scientific Topic: ”A Tale of Two Schools: Statistical Tests Revisited”• Pedagogic report: ”Report of a class on Correlation and Linear Regression”• Advisor: Altamiro Costa-Pereira

University of Sheffield, Medical Care Research Unit , Sheffield, UK Jun to Sep 1996Internship as a Statistician

Universidad Complutense, Faculty of Mathematics, Madrid, Spain Oct 1994 to Feb 1995Interchange Program - Erasmus in Mathematics

University of Porto, Faculty of Sciences, Porto, Portugal Feb 1996Licenciatura in Applied Mathematics (equivalent to a BSc.)

ACADEMICAPPOINTMENTS

Sydney School of Public Health, The University of Sydney, Sydney, Australia Feb 2020 - presentProfessor of Biostatistics

University of Porto, Porto, Portugal Jan 2021 - presentAffiliated Professor (honorary)

Sydney School of Public Health, The University of Sydney, Sydney, Australia Jan 2017 - Jan 2020Associate Professor

Sydney School of Public Health, The University of Sydney, Sydney, Australia Jan 2019 - presentAcademic Leader Research Education

Sydney School of Public Health, The University of Sydney, Sydney, Australia Jul 2012 - Jan 2017Senior Research Fellow and Senior Lecturer

Faculty of Medicine, University of Porto, Porto, Portugal Feb 2007 - Jul 2012Assistant Professor

Faculty of Medicine, University of Porto, Porto, Portugal Jul 1996 - Jan 2007Teaching Assistant

Harvard School of Public Health, Boston, USA Jan 2005 - Apr 2007Teaching Assistant

Children’s Hospital, Boston, USA Jul 2002 - Aug 2004Research Assistant

Faculty of Nutrition, University of Porto, Porto, Portugal Jan 1996 - Jul 1996Assistant Lecturer

HONOURS ANDAWARDS

• Visiting Academic, Faculty of Medicine, University of Porto, Portugal, since 2019• Invited Faculty for the Principles and Practices of Clinical Research workshop, Harvard University ,

since 2016• Young Researcher Support for the Workshop on Statistical Theory and Methods for Complex, High-

Dimensional Data, Isaac Newton Institute for Mathematical Sciences: UK, 2008• Research prize: Premio Sociedade Portuguesa de Pediatria, 2007• Research prize: Premio Hemoportugal em Ecocardiografia, 2007• Merck Company Foundation Quantitative Sciences Fellowship, Harvard School of Public Health, 2006• Phd Scholarship, Harvard University 2002-2006• Margaret E. Drolette Memorial Fund Award for International Students, Harvard School of Public

Health, 2005• Financial support to participate in the Global Chinese conference on computers in education - GC-

CCE99, Gulbenkian Foundation, 1999

RESEARCHINTERESTS

My methodological research focuses on the development of multivariate statistical methods for theanalysis of multiple outcomes. In particular, methods for jointly modelling outcomes measured on dif-ferent scales (non-commensurate outcomes) and methods for pooling information for decision makingin situations of multivariate outcomes.Regarding collaborative research I have been involved in several projects of clinical, epidemiologicaland health services research with focus on kidney research. I co-lead the Centre fo Kidney Research atthe Westmead Children’s Hospital, which includes more than 40 researchers.

RESEARCHPROJECTS WITHFINANCIALSUPPORT

The next generation of evidence on cardiovascular diseaseprevention using device-based assessments of physical behaviour 2021in harmonised pooled cohorts: The Prospective Physical Activity, Sittingand Sleep consortium (ProPASS)(British Heart Foundation). 1,500,000AUD

Structured exercise program to reduce fatigue in patientsreceiving dialysis: a preference-stratified adaptive trial (M-FIT)(Co-investigator) 2020National Health and Medical Research Council (NHMRC - MRFF). 1,960,000AUD

ACCESS: Aboriginal Community Controlled Ear health SupportSystem: developing, embedding and evaluating best practice models of care (Co-investigator) 2020National Health and Medical Research Council (NHMRC - MRFF). 887, 000AUD

Evidence on the clinical effectiveness and cost-effectiveness ofdigital breast tomosynthesis in identifying breast cancer comparedto standard imaging in populations at risk of breast cancer(Co-investigator) 2020National Health and Medical Research Council (NHMRC - MRFF). 1,422,000AUD

Antecedents of Renal Disease in Aboriginal Children andyoung adults (ARDAC)(Co-investigator) 2020National Health and Medical Research Council (NHMRC). 1,700,000AUD

The assessment of novel immunological risk profile to establish the most suitable parental donorfor kidney transplantation: “Best-Parent” study (ELIMINATE). (Co-investigator) 2020National Health and Medical Research Council (NHMRC). 1,833,663 AUD

NAVMAN TRIAL: A multi-centre, dynamic, waitlist randomised controlledtrial of patient navigators in children with chronic kidney disease. (Co-investigator). 2019National Health and Medical Research Council (NHMRC)MRFF - Research Grants. 1,093,680AUD

A randomised controlled trial, of N-Acetyl Cysteine, for premanifestHuntington gene expansion carriers (NAC-preHD). (Co-investigator). 2018National Health and Medical Research Council (NHMRC)Lifting Clinical Trials and Registries Capacity (LCTRC). 1,905,227AUD

eADVICE (electronic Advice and Diagnosis Via the Internet following ComputerisedEvaluation), an interactive eHealth program for reducing waiting times in paediatric 2018-2020outpatient clinics (Co-investigator).Translational Research Grants Scheme (TRGS) NSW Health. 493,706AUD

How best to understand data collected from continuous monitoring tests? (Co-investigator). 2017

Collaboration Research Scheme Sydney University. 4,000AUD

Safety, tolerability and effect on inflammatory marker of colchicine in kidney 2017transplant recipients (Co-investigator).Sir Charles Gairdner Osborne Park Health Care Group, 37,017AUD

Better evidence, better care and outcomes for people withchronic kidney disease (Associate Investigator) 2016National Health and Medical Research Council (NHMRC) 10,141,300AUD

Pilot study of using a ”Potty Monkey” for toilet training in children with 2016special need (Co-investigator).The Australian Bladder Foundation, 10,000AUD

Improving the identification of depression in Aboriginal and Torres Strait Islander 2014 - 2017people (Co-Investigator). NHMRC - APP1061767, 641,456AUD

A randomised trial to investigate whether ’heart age’ can improve cardiovascular 2014disease prevention (Associate Investigator). Heart Foundation, 67,168AUD

Comparative use of technologies for coronary heart disease (Associate Investigator). 2013 - 2016Portuguese National Foundation of Science and Technologies.HMSP-ICT/0018/2011, 400.000e

Regression Methods for Non-commensurate Outcomes. (PI: Teixeira-Pinto A). 2010 - 2012National Foundation for Science and Technology.PTDC/SAU-ESA/100841/2008, 59,938e

Engaging the Community in the prevention of neglected tropical 2011 - 2013diseases: a pilot study in Guine-Bissau. (PI: Sousa L and Teixeira-Pinto A)Gulbenkian Foundation, 152,840e

Phase II trial of the addition of Lapatinib to Capecitabine versus Capecitabine 2012 - 2014alone as radio-sensitizers in KRAS wild type resectable rectal cancer. (PI: Sousa N).Co-Investigator/Statistician. GlaxoSmithKline, 80,400e

Prevention of skeletal related events with long term treatment with 2010 - 2012with zoledronic acid. (PI: Sousa N). Co-Investigator/Statistician. Novartis, 50,000e

Project OPTIM - Optimizing Information Systems for Healthcare. (PI: Correia R). 2010 - 2012National Foundation for Science and Technology - PTDC/EIA-EIA/099920/2008, 86,481e

The PIRO concept - implementation and validation of a new classification 2009 - 2012system for septic patients. (PI: Granja C). Co-Investigator/Statistician.National Foundation for Science and Technology - PIC/IC/83312/2007, 50,000e

HR-QoD - Quality of data (outliers, inconsistencies and errors) in hospital 2009 - 2012inpatient databases: methods and implications for data modeling, cleansingand analysis. (PI: Costa-Pereira A). Co-Investigator/Statistician. National Foundation forScience and Technology - PIC/ SAU-ESA/75660/2006, 161,332e

Quality of life after pediatric intensive care. (PI: Almeida-Santos, A). 2005 - 2008(Co-Investigator/Statistician). National Foundation for Science andTechnology - PIC/ SAU-ESP/59260/2004, 39,907e

PUBLICATIONS Full articles in peer-reviewed journals,editorials and reviews[1] A. D. Althouse, J. E. Below, B. L. Claggett, N. J. Cox, de J. A. Lemos, R. C. Deo, S. Duval,

R. Hachamovitch, S. Kaul, S. W. Keith, E. Secemsky, A. Teixeira-Pinto, and V. L. Roger. Rec-ommendations for statistical reporting in cardiovascular medicine: A special report from theamerican heart association. Circulation, 144(4):e70–e91, 2021.

[2] K. J. Bell, F. F. Stanaway, L. M. Irwig, A. R. Horvath, A. Teixeira-Pinto, and C. Loy. How to useimperfect tests for covid-19 (sars-cov-2) to make clinical decisions. Med J Aust, 214(2):69–73 e1,2021.

[3] K. J. L. Bell, C. Loy, A. E. Cust, and A. Teixeira-Pinto. Mendelian randomization in cardiovascularresearch: Establishing causality when there are unmeasured confounders. Circ Cardiovasc Qual

Outcomes, 14(1):e005623, 2021.

[4] K. Blazek, van A. Zwieten, V. Saglimbene, and A. Teixeira-Pinto. A practical guide to multipleimputation of missing data in nephrology. Kidney Int, 99(1):68–74, 2021.

[5] S. A. Carter, C. Logeman, M. Howell, D. Cattran, L. Lightstone, A. Bagga, S. J. Barbour, J. Barratt,J. Boletis, D. J. Caster, R. Coppo, F. C. Fervenza, J. Floege, M. A. Hladunewich, J. J. Hogan,A. R. Kitching, R. A. Lafayette, A. Malvar, J. Radhakrishnan, B. H. Rovin, N. Scholes-Robertson,H. Trimarchi, H. Zhang, Y. Cho, L. Dunn, D. S. Gipson, A. Liew, B. Sautenet, A. K. Viecelli,D. Harris, D. W. Johnson, A. Y. Wang, A. Teixeira-Pinto, S. I. Alexander, A. Martin, A. Tong, andJ. C. Craig. Development of an international delphi survey to establish core outcome domainsfor trials in adults with glomerular disease. Kidney Int, 2021.

[6] Y. Cho, A. Tong, J. C. Craig, R. A. Mustafa, A. Chapman, R. D. Perrone, C. Ahn, K. Fowler,V. Torres, R. T. Gansevoort, A. C. M. Ong, H. Coolican, J. Tze-Wah Kao, T. Harris, T. Gutman, J. I.Shen, A. K. Viecelli, D. W. Johnson, E. Au, R. El-Damanawi, C. Logeman, A. Ju, K. E. Manera,M. Chonchol, D. Odland, D. Baron, Y. Pei, B. Sautenet, A. Rastogi, A. Sharma, G. Rangan, and S.-P. W. Investigators. Establishing a core outcome set for autosomal dominant polycystic kidneydisease: Report of the standardized outcomes in nephrology-polycystic kidney disease (song-pkd) consensus workshop. Am J Kidney Dis, 77(2):255–263, 2021.

[7] J. Dawson, K. L. Campbell, J. C. Craig, A. Tong, A. Teixeira-Pinto, M. A. Brown, K. Howard,M. Howell, R. Khalid, K. Sud, A. Thiagalingam, C. K. Chow, and V. W. Lee. A text messagingintervention for dietary behaviors for people receiving maintenance hemodialysis: A feasibilitystudy of kidneytext. Am J Kidney Dis, 78(1):85–95 e1, 2021.

[8] B. P. Doucet, Y. Cho, S. B. Campbell, D. W. Johnson, C. M. Hawley, A. R. M. Teixeira-Pinto, andN. M. Isbel. Kidney transplant outcomes in elderly recipients: An australia and new zealanddialysis and transplant (anzdata) registry study. Transplant Proc, 2021.

[9] H. Htay, D. W. Johnson, J. C. Craig, A. Teixeira-Pinto, C. M. Hawley, and Y. Cho. Urgent-start peritoneal dialysis versus haemodialysis for people with chronic kidney disease. CochraneDatabase Syst Rev, 1:CD012899, 2021.

[10] K. Leow, P. Szulc, J. T. Schousboe, D. P. Kiel, A. Teixeira-Pinto, H. Shaikh, M. Sawang, M. Sim,N. Bondonno, J. M. Hodgson, A. Sharma, P. L. Thompson, R. L. Prince, J. C. Craig, W. H. Lim,G. Wong, and J. R. Lewis. Prognostic value of abdominal aortic calcification: A systematic reviewand meta-analysis of observational studies. J Am Heart Assoc, 10(2):e017205, 2021.

[11] P. Natale, V. Saglimbene, M. Ruospo, A. M. Gonzalez, G. F. Strippoli, N. Scholes-Robertson,C. Guha, J. C. Craig, A. Teixeira-Pinto, T. Snelling, and A. Tong. Transparency, trust and minimiz-ing burden to increase recruitment and retention in trials: a systematic review. J Clin Epidemiol,134:35–51, 2021.

[12] Y. P. See, H. Htay, A. Teixeira-Pinto, E. M. Pascoe, C. Hawley, Y. Cho, E. Zhao, and D. W. Johnson.Utility of serum beta-trace protein as a tool for estimating residual kidney function in peritonealdialysis patients. Perit Dial Int, 41(2):226–235, 2021.

[13] V. Sinka, P. Lopez-Vargas, A. Tong, M. Dickson, M. Kerr, N. Sheerin, K. Blazek, A. Teixeira-Pinto, J. H. Stephens, and J. C. Craig. Chronic disease prevention programs offered by aboriginalcommunity controlled health services in new south wales, australia. Aust N Z J Public Health,45(1):59–64, 2021.

[14] F. Stanaway, L. M. Irwig, A. Teixeira-Pinto, and K. J. Bell. Covid-19: estimated number of deathsif australia had experienced a similar outbreak to england and wales. Med J Aust, 214(2):95–95e1, 2021.

[15] A. Teixeira-Pinto. Of scandals and statistics: Improving analytical methods in clinical and healthservices research. Circ Cardiovasc Qual Outcomes, 14(7):e008279, 2021.

[16] A. Tong, A. Baumgart, N. Evangelidis, A. K. Viecelli, S. A. Carter, L. C. Azevedo, T. Cooper,A. Bersten, L. Cervantes, D. P. Chew, S. Crowe, I. S. Douglas, E. Flemyng, J. H. Elliott, E. Han-nan, P. Horby, M. Howell, A. Ju, J. Lee, E. Lorca, D. Lynch, K. E. Manera, J. C. Marshall, A. M.Gonzalez, A. McKenzie, S. Mehta, M. Mer, A. C. Morris, D. M. Needham, S. Nseir, P. Povoa,M. Reid, Y. Sakr, N. Shen, A. R. Smyth, A. J. Simpson, T. Snelling, G. F. M. Strippoli, A. Teixeira-Pinto, A. Torres, T. Turner, S. Webb, P. R. Williamson, L. Woc-Colburn, J. Zhang, J. C. Craig, andC. O.-.-C. O. S. Investigators. Core outcome measures for trials in people with coronavirus dis-ease 2019: Respiratory failure, multiorgan failure, shortness of breath, and recovery. Crit CareMed, 49(3):503–516, 2021.

[17] A. Tong, T. C. Sorrell, A. J. Black, C. Caillaud, W. Chrzanowski, E. Li, D. Martinez-Martin,A. McEwan, R. Wang, A. Motion, A. C. Bedoya, J. Huang, L. Azizi, B. J. Eggleton, and C.-S. R. P.-S. Investigators. Research priorities for covid-19 sensor technology. Nat Biotechnol, 39(2):144–147,2021.

[18] van A. Zwieten, A. Teixeira-Pinto, S. Lah, N. Nassar, J. C. Craig, and G. Wong. Socioeconomicstatus during childhood and academic achievement in secondary school. Acad Pediatr, 21(5):838–848, 2021.

[19] E. H. Au, A. Francis, A. Bernier-Jean, and A. Teixeira-Pinto. Prediction modeling-part 1: regres-sion modeling. Kidney Int, 97(5):877–884, 2020.

[20] A. Baumgart, K. E. Manera, D. W. Johnson, J. C. Craig, J. I. Shen, L. Ruiz, A. Y. Wang, T. Yip,S. K. S. Fung, M. Tong, A. Lee, Y. Cho, A. K. Viecelli, B. Sautenet, A. Teixeira-Pinto, E. A. Brown,G. Brunier, J. Dong, N. Scholes-Robertson, T. Dunning, R. Mehrotra, S. Naicker, R. Pecoits-Filho,J. Perl, M. Wilkie, and A. Tong. Meaning of empowerment in peritoneal dialysis: focus groupswith patients and caregivers. Nephrol Dial Transplant, 35(11):1949–1958, 2020.

[21] A. Bernier-Jean, R. L. Prince, J. R. Lewis, J. C. Craig, J. M. Hodgson, W. H. Lim, A. Teixeira-Pinto,and G. Wong. Dietary plant and animal protein intake and decline in estimated glomerularfiltration rate among elderly women: a 10-year longitudinal cohort study. Nephrol Dial Transplant,2020.

[22] S. A. Carter, T. Gutman, C. Logeman, D. Cattran, L. Lightstone, A. Bagga, S. J. Barbour, J. Bar-ratt, J. Boletis, D. Caster, R. Coppo, F. C. Fervenza, J. Floege, M. Hladunewich, J. J. Hogan,A. R. Kitching, R. A. Lafayette, A. Malvar, J. Radhakrishnan, B. H. Rovin, N. Scholes-Robertson,H. Trimarchi, H. Zhang, K. Azukaitis, Y. Cho, A. K. Viecelli, L. Dunn, D. Harris, D. W. Johnson,P. G. Kerr, P. Laboi, J. Ryan, J. I. Shen, L. Ruiz, A. Y. Wang, A. H. K. Lee, S. Fung, M. K. Tong,A. Teixeira-Pinto, M. Wilkie, S. I. Alexander, J. C. Craig, A. Tong, and S.-G. Investigators. Iden-tifying outcomes important to patients with glomerular disease and their caregivers. Clin J AmSoc Nephrol, 15(5):673–684, 2020.

[23] S. A. Carter, A. Tong, T. Gutman, N. Scholes-Robertson, A. Teixeira-Pinto, M. Howell, andJ. C. Craig. Controversy and debate series on core outcome sets. paper 5: Large-scale, mixed-methods, knowledge exchange to establish core outcomes - the song approach. J Clin Epidemiol,125:225–228, 2020.

[24] Y. Cho, G. Rangan, C. Logeman, H. Ryu, B. Sautenet, R. D. Perrone, A. C. Nadeau-Fredette, R. A.Mustafa, H. Htay, M. Chonchol, T. Harris, T. Gutman, J. C. Craig, A. C. M. Ong, A. Chapman,C. Ahn, H. Coolican, J. T. Kao, R. T. Gansevoort, V. Torres, Y. Pei, D. W. Johnson, A. K. Viecelli,A. Teixeira-Pinto, M. Howell, A. Ju, K. E. Manera, and A. Tong. Core outcome domains for trialsin autosomal dominant polycystic kidney disease: An international delphi survey. Am J KidneyDis, 76(3):361–373, 2020.

[25] M. H. Connors, K. Seeher, A. Teixeira-Pinto, M. Woodward, D. Ames, and H. Brodaty. Dementiaand caregiver burden: A three-year longitudinal study. Int J Geriatr Psychiatry, 35(2):250–258,2020.

[26] M. H. Connors, A. Teixeira-Pinto, and C. T. Loy. Psychosis and longitudinal outcomes in hunt-ington disease: the cohort study. J Neurol Neurosurg Psychiatry, 91(1):15–20, 2020.

[27] A. R. Costa, M. Sousa, S. P. Wilson, C. Reguenga, A. Teixeira-Pinto, I. Tavares, and I. Martins.Shift of micro-opioid receptor signaling in the dorsal reticular nucleus is implicated in morphine-induced hyperalgesia in male rats. Anesthesiology, 133(3):628–644, 2020.

[28] da A. M. Silva, C. Torres, I. Ferreira, I. Moreira, R. Samoes, A. P. Sousa, E. Santos, A. Teixeira-Pinto, and S. Cavaco. Prognostic value of odor identification impairment in multiple sclerosis:10-years follow-up. Mult Scler Relat Disord, 46:102486, 2020.

[29] N. Evangelidis, A. Tong, M. Howell, A. Teixeira-Pinto, J. H. Elliott, L. C. Azevedo, A. Bersten,L. Cervantes, D. P. Chew, S. Crowe, I. S. Douglas, E. Flemyng, P. Horby, J. Lee, E. Lorca, D. Lynch,J. C. Marshall, A. McKenzie, S. Mehta, M. Mer, A. C. Morris, S. Nseir, P. Povoa, M. Reid,Y. Sakr, N. Shen, A. R. Smyth, T. Snelling, G. F. M. Strippoli, A. Torres, T. Turner, S. Webb, P. R.Williamson, L. Woc-Colburn, J. Zhang, A. Baumgart, S. Cabrera, Y. Cho, T. Cooper, C. Guha,E. Liu, A. M. Gonzalez, C. McLeod, P. Natale, V. Saglimbene, A. K. Viecelli, J. C. Craig, andC. O.-.-C. O. S. S. Investigators. International survey to establish prioritized outcomes for trialsin people with coronavirus disease 2019. Crit Care Med, 48(11):1612–1621, 2020.

[30] A. M. Gonzalez, T. Gutman, P. Lopez-Vargas, S. Anumudu, C. M. Arce, J. C. Craig, L. Dunn, K. U.Eckardt, T. Harris, A. S. Levey, L. Lightstone, N. Scholes-Robertson, J. I. Shen, A. Teixeira-Pinto,D. C. Wheeler, D. White, M. Wilkie, M. Jadoul, W. C. Winkelmayer, and A. Tong. Patient andcaregiver priorities for outcomes in ckd: A multinational nominal group technique study. Am JKidney Dis, 76(5):679–689, 2020.

[31] C. Guha, P. Lopez-Vargas, A. Ju, T. Gutman, N. J. Scholes-Robertson, A. Baumgart, G. Wong,J. Craig, T. Usherwood, S. Reid, V. Cullen, M. Howell, R. Khalid, A. Teixeira-Pinto, K. Wyburn,S. Sen, T. Smolonogov, V. W. Lee, G. K. Rangan, A. Matus Gonzales, A. Tong, and P.-C. w. investi-gators. Patient needs and priorities for patient navigator programmes in chronic kidney disease:a workshop report. BMJ Open, 10(11):e040617, 2020.

[32] C. S. Hanson, J. C. Craig, C. Logeman, A. Sinha, A. Dart, A. A. Eddy, C. Guha, D. S. Gipson,D. Bockenhauer, H. K. Yap, J. Groothoff, M. Zappitelli, N. J. A. Webb, S. I. Alexander, S. L. Furth,S. Samuel, A. Neu, A. K. Viecelli, A. Ju, A. Sharma, E. H. Au, H. Desmond, J. I. Shen, K. E. Man-era, K. Azukaitis, L. Dunn, S. A. Carter, T. Gutman, Y. Cho, A. Walker, A. Francis, C. Sanchez-Kazi, J. Kausman, M. Pearl, N. Benador, S. Sahney, A. Tong, and S. O.-K. c. w. investigators.Establishing core outcome domains in pediatric kidney disease: report of the standardized out-comes in nephrology-children and adolescents (song-kids) consensus workshops. Kidney Int,98(3):553–565, 2020.

[33] F. L. Heggendorn, L. A. L. Teixeira Pinto, L. S. Goncalves, V. O. F. Lione, W. B. Cravo Junior, andM. T. Soares Lutterbach. Biocorrosive behavior of sulphate-reducing bacteria in kerr endodonticfiles: Determination of the corrosion. J Conserv Dent, 23(2):196–200, 2020.

[34] H. Htay, D. W. Johnson, J. C. Craig, A. Teixeira-Pinto, C. M. Hawley, and Y. Cho. Urgent-startperitoneal dialysis versus conventional-start peritoneal dialysis for people with chronic kidneydisease. Cochrane Database Syst Rev, 12:CD012913, 2020.

[35] A. Ju, A. Teixeira-Pinto, A. Tong, A. C. Smith, M. Unruh, S. N. Davison, J. Dapueto, M. A. Dew,R. Fluck, M. J. Germain, S. V. Jassal, G. T. Obrador, D. O’Donoghue, A. K. Viecelli, G. Strippoli,M. Ruospo, D. Timofte, A. Sharma, E. Au, M. Howell, D. S. J. Costa, S. Anumudu, J. C. Craig,and C. Rutherford. Validation of a core patient-reported outcome measure for fatigue in patientsreceiving hemodialysis: The song-hd fatigue instrument. Clin J Am Soc Nephrol, 15(11):1614–1621, 2020.

[36] A. Kelly, K. Tymms, de M. Wit, S. J. Bartlett, M. Cross, T. Dawson, M. De Vera, V. Evans, M. Gill,G. Hassett, I. Lim, K. Manera, G. Major, L. March, S. O’Neill, M. Scholte-Voshaar, P. Sinnathurai,D. Sumpton, A. Teixeira-Pinto, P. Tugwell, van den B. Bemt, and A. Tong. Patient and caregiverpriorities for medication adherence in gout, osteoporosis, and rheumatoid arthritis: Nominalgroup technique. Arthritis Care Res (Hoboken), 72(10):1410–1419, 2020.

[37] A. Killedar, T. Lung, S. Petrou, A. Teixeira-Pinto, and A. Hayes. Estimating age- and sex-specificutility values from the chu9d associated with child and adolescent bmi z-score. Pharmacoeco-nomics, 38(4):375–384, 2020.

[38] A. Killedar, T. Lung, S. Petrou, A. Teixeira-Pinto, E. J. Tan, and A. Hayes. Weight status andhealth-related quality of life during childhood and adolescence: effects of age and socioeconomicposition. Int J Obes (Lond), 44(3):637–645, 2020.

[39] A. Krishnan, A. Teixeira-Pinto, W. H. Lim, K. Howard, J. R. Chapman, A. Castells, S. D. Roger,M. J. Bourke, P. Macaskill, G. Williams, C. E. Lok, F. Diekmann, N. Cross, S. Sen, R. D. M. Allen,S. J. Chadban, C. A. Pollock, R. Turner, A. Tong, J. Y. H. Yang, N. Williams, E. Au, A. Kieu,L. James, A. Francis, G. Wong, and J. C. Craig. Health-related quality of life in people across thespectrum of ckd. Kidney Int Rep, 5(12):2264–2274, 2020.

[40] R. Lalji, A. Francis, G. Wong, A. K. Viecelli, A. Tong, A. Teixeira-Pinto, M. McCulloch, A. K.Bello, A. Levin, M. Lunney, M. A. Osman, F. Ye, V. Jha, J. Feehally, D. C. Harris, and D. W.Johnson. Disparities in end-stage kidney disease care for children: a global survey. Kidney Int,98(3):527–532, 2020.

[41] M. F. Lobo, V. Azzone, F. Lopes, A. Freitas, A. Costa-Pereira, S. L. Normand, and A. Teixeira-Pinto. Understanding the large heterogeneity in hospital readmissions and mortality for acutemyocardial infarction. Health Policy, 124(7):684–694, 2020.

[42] C. Logeman, Y. Cho, B. Sautenet, G. K. Rangan, T. Gutman, J. Craig, A. Ong, A. Chapman,C. Ahn, H. Coolican, J. Tze-Wah Kao, R. T. Gansevoort, R. Perrone, T. Harris, V. Torres, K. Fowler,Y. Pei, P. Kerr, J. Ryan, D. Johnson, A. Viecelli, C. Geneste, H. Kim, Y. Kim, M. Howell, A. Ju,K. E. Manera, A. Teixeira-Pinto, G. Parasivam, and A. Tong. ’a sword of damocles’: patient andcaregiver beliefs, attitudes and perspectives on presymptomatic testing for autosomal dominantpolycystic kidney disease: a focus group study. BMJ Open, 10(10):e038005, 2020.

[43] C. Logeman, C. Guha, M. Howell, C. S. Hanson, J. C. Craig, S. Samuel, M. Zappitelli,M. Matsuda-Abedini, A. Dart, S. Furth, A. Eddy, J. Groothoff, H. K. Yap, D. Bockenhauer,A. Sinha, S. I. Alexander, S. L. Goldstein, D. S. Gipson, M. Michael, A. Walker, J. Kausman,S. Gaillard, J. Bacchetta, M. N. Rheault, B. A. Warady, A. Neu, M. Christian, S. McTaggart, I. Liu,S. Teo, B. Sautenet, T. Gutman, S. Carter, A. Teixeira-Pinto, and A. Tong. Developing consensus-based outcome domains for trials in children and adolescents with ckd: An international delphisurvey. Am J Kidney Dis, 76(4):533–545, 2020.

[44] K. E. Manera, D. W. Johnson, J. C. Craig, J. I. Shen, T. Gutman, Y. Cho, A. Y.-M. Wang, E. A.Brown, G. Brunier, J. Dong, T. Dunning, R. Mehrotra, S. Naicker, R. Pecoits-Filho, J. Perl,M. Wilkie, A. Tong, A. Levin, A. Liew, A. Cueto Manzano, A. Abu Alfa, A. Neu, A. Tong,A. Baumgart, A. Bernier-Jean, A. Kelly, A. Figueiredo, A. Matus, A. Viecelli, A. Ju, A. Y.-M.Wang, A. Saxena, A. Sharma, A.-C. Nadeau-Fredette, A. Teixeira-Pinto, A. Mendelson, A. Kelly,B. L. Goh, B. Sautenet, B. Manns, B. Hemmelgarn, B. Robinson, C. Hanson, C. Cheung, C. Guha,

C. Logeman, C.-C. Szeto, C. Rutherford, D. Schwartz, D. Sumpton, D. Johnson, D. Wheeler,E. Brown, E. O’Lone, E. Au, E. Goffin, F. Finkelstein, G. Abraham, G. Brunier, G. Germino,H. Hurst, H. Kawanishi, H. Htay, H. K. Yap, I. Teitelbaum, J. Perl, J. Chen, J. Shen, J. Dong,J. Neumann, J. Bargman, J. Morelle, J. Craig, K. G. Kilonzo, K. Yeates, K. Manera, K. Azukaitis,K. L. Van, L. Dunn, M. Krishnan, M. Lambie, M. Howell, M. Schreiber, M. Wilkie, M. Oliver, M. R.Sanabria, M. Nataatmadja, M. Lichodziejewska-Niemierko, N. Verdin, N. Mann, N. Boudville,N. Evangelidis, N. Scholes-Robertson, P. Blake, P. Nourse, P. Tugwell, P. K.-T. Li, R. Mehrotra,R. McGee, R. Quinn, et al. Establishing a core outcome set for peritoneal dialysis: Report ofthe song-pd (standardized outcomes in nephrology–peritoneal dialysis) consensus workshop.American Journal of Kidney Diseases, 75(3):404–412, 2020.

[45] P. Natale, T. Gutman, M. Howell, K. Dansie, C. M. Hawley, Y. Cho, A. K. Viecelli, J. C. Craig,S. Jesudason, J. R. Chapman, D. W. Johnson, L. Murphy, D. Reidlinger, S. Crowe, E. Duncanson,S. Muthuramalingam, N. Scholes-Robertson, A. Williamson, S. McDonald, G. Wong, A. Teixeira-Pinto, G. F. M. Strippoli, A. Tong, E. Better, and Translation in I. Chronic Kidney Disease Work-shop. Recruitment and retention in clinical trials in chronic kidney disease: report from nationalworkshops with patients, caregivers and health professionals. Nephrol Dial Transplant, 2020.

[46] V. M. Saglimbene, G. Wong, A. Teixeira-Pinto, M. Ruospo, V. Garcia-Larsen, S. C. Palmer, P. Na-tale, K. Campbell, J. J. Carrero, P. Stenvinkel, L. Gargano, A. M. Murgo, D. W. Johnson, M. Tonelli,R. Gelfman, E. Celia, T. Ecder, A. G. Bernat, D. Del Castillo, D. Timofte, M. Torok, A. Bednarek-Skublewska, J. Dulawa, P. Stroumza, M. Hansis, E. Fabricius, P. Felaco, C. Wollheim, J. Hegbrant,J. C. Craig, G. F. M. Strippoli, D.-H. Investigators, and Dieticians. Dietary patterns and mortalityin a multinational cohort of adults receiving hemodialysis. Am J Kidney Dis, 75(3):361–372, 2020.

[47] V. M. Saglimbene, G. Wong, van A. Zwieten, S. C. Palmer, M. Ruospo, P. Natale, K. Campbell,A. Teixeira-Pinto, J. C. Craig, and G. F. M. Strippoli. Effects of omega-3 polyunsaturated fattyacid intake in patients with chronic kidney disease: Systematic review and meta-analysis ofrandomized controlled trials. Clin Nutr, 39(2):358–368, 2020.

[48] A. Sharma, A. Taverniti, N. Graf, A. Teixeira-Pinto, J. R. Lewis, W. H. Lim, S. I. Alexander,A. Durkan, J. C. Craig, and G. Wong. The association between human leukocyte antigen epletmismatches, de novo donor-specific antibodies, and the risk of acute rejection in pediatric kidneytransplant recipients. Pediatr Nephrol, 35(6):1061–1068, 2020.

[49] A. Tong, J. H. Elliott, L. C. Azevedo, A. Baumgart, A. Bersten, L. Cervantes, D. P. Chew, Y. Cho,T. Cooper, S. Crowe, I. S. Douglas, N. Evangelidis, E. Flemyng, E. Hannan, P. Horby, M. Howell,J. Lee, E. Liu, E. Lorca, D. Lynch, J. C. Marshall, A. M. Gonzalez, A. McKenzie, K. E. Manera,C. McLeod, S. Mehta, M. Mer, A. C. Morris, S. Nseir, P. Povoa, M. Reid, Y. Sakr, N. Shen, A. R.Smyth, T. Snelling, G. F. Strippoli, A. Teixeira-Pinto, A. Torres, T. Turner, A. K. Viecelli, S. Webb,P. R. Williamson, L. Woc-Colburn, J. Zhang, J. C. Craig, and C. O.-.-C. O. S. W. Investigators. Coreoutcomes set for trials in people with coronavirus disease 2019. Crit Care Med, 48(11):1622–1635,2020.

[50] van A. Zwieten, A. Teixeira-Pinto, S. Lah, N. Nassar, J. C. Craig, and G. Wong. Socioeconomicstatus during childhood and academic achievement in secondary school. Acad Pediatr, 2020.

[51] A. K. Viecelli, M. Howell, A. Tong, A. Teixeira-Pinto, E. O’Lone, A. Ju, J. C. Craig, L. S. Hooi,T. Lee, C. E. Lok, K. R. Polkinghorne, R. R. Quinn, T. J. Vachharajani, R. Vanholder, L. Zuo, J. Tor-doir, R. Pecoits-Filho, T. Yuo, P. Kopperschmidt, R. Smith, A. B. Irish, T. A. Mori, E. M. Pascoe,D. W. Johnson, and C. M. Hawley. Identifying critically important vascular access outcomes fortrials in haemodialysis: an international survey with patients, caregivers and health profession-als. Nephrol Dial Transplant, 35(4):657–668, 2020.

[52] G. Wong, J. Marsh, M. Howell, W. H. Lim, S. Chadban, T. Coates, C. Hawley, S. Campbell,N. Larkins, T. Snelling, L. Allan, A. Teixeira-Pinto, D. Reidlinger, K. Wyburn, and J. C. Craig.Screening and management practices for polyoma (bk) viremia and nephropathy in kidneytransplant recipients from the lands down under: Addressing the unknowns and rationale for amulticenter clinical trial. Kidney Int Rep, 5(10):1777–1780, 2020.

[53] E. H. Au, J. R. Chapman, J. C. Craig, W. H. Lim, A. Teixeira-Pinto, S. Ullah, S. McDonald, andG. Wong. Overall and site-specific cancer mortality in patients on dialysis and after kidneytransplant. J Am Soc Nephrol, 2019.

[54] S. A. Carter, L. Lightstone, D. Cattran, A. Bagga, S. J. Barbour, J. Barratt, J. Boletis, D. Caster,R. Coppo, F. C. Fervenza, J. Floege, M. Hladunewich, J. J. Hogan, A. R. Kitching, R. Lafayette,A. Malvar, J. Radhakrishnan, B. H. Rovin, H. Zhang, T. Gutman, M. Howell, C. Logeman, J. I.Shen, A. Teixeira-Pinto, S. I. Alexander, Y. Cho, J. C. Craig, D. Harris, D. W. Johnson, P. G. Kerr,J. Ryan, A. K. Viecelli, A. Y. Wang, M. Wilkie, N. Scholes-Robertson, A. Tong, and S.-G. Initia-tive. Standardized outcomes in nephrology-glomerular disease (song-gd): establishing a coreoutcome set for trials in patients with glomerular disease. Kidney Int, 95(6):1280–1283, 2019.

[55] Y. Cho, B. Sautenet, T. Gutman, G. Rangan, J. C. Craig, A. C. Ong, A. Chapman, C. Ahn, H. Cooli-can, J. T. Kao, R. Gansevoort, R. D. Perrone, T. Harris, V. Torres, Y. Pei, P. G. Kerr, J. Ryan, D. W.Johnson, A. K. Viecelli, C. Geneste, H. Kim, Y. Kim, Y. K. Oh, A. Teixeira-Pinto, C. Logeman,M. Howell, A. Ju, K. E. Manera, and A. Tong. Identifying patient-important outcomes in poly-cystic kidney disease: An international nominal group technique study. Nephrology (Carlton),24(12):1214–1224, 2019.

[56] M. H. Connors, K. Seeher, A. Teixeira-Pinto, M. Woodward, D. Ames, and H. Brodaty. Mildcognitive impairment and caregiver burden: A 3-year-longitudinal study. Am J Geriatr Psychiatry,27(11):1206–1215, 2019.

[57] M. Didsbury, van A. Zwieten, K. Chen, L. J. James, A. Francis, S. Kim, S. McTaggart, A. Walker,F. Mackie, T. Kara, C. Prestidge, A. Teixeira-Pinto, B. Barton, J. Lorenzo, S. Lah, K. Howard,N. Nassar, E. Au, A. Tong, J. C. Craig, and G. Wong. The association between socioeconomicdisadvantage and parent-rated health in children and adolescents with chronic kidney disease-the kids with ckd (kcad) study. Pediatr Nephrol, 34(7):1237–1245, 2019.

[58] S. Farnbach, G. Gee, A. M. Eades, J. R. Evans, J. Fernando, B. Hammond, M. Simms, K. DeMasi,N. Glozier, A. Brown, M. L. Hackett, and Getting it I. Right. Process evaluation of the getting itright study and acceptability and feasibility of screening for depression with the aphq-9. BMCPublic Health, 19(1):1270, 2019.

[59] S. Farnbach, G. Gee, A. M. Eades, J. R. Evans, J. Fernando, B. Hammond, M. Simms, K. DeMasi,M. L. Hackett, and Getting it I. Right. ’we’re here to listen and help them as well’: a qualitativestudy of staff and indigenous patient perceptions about participating in social and emotionalwellbeing research at primary healthcare services. BMC Psychiatry, 19(1):294, 2019.

[60] A. Francis, M. S. Didsbury, van A. Zwieten, K. Chen, L. J. James, S. Kim, K. Howard, G. Williams,O. Bahat Treidel, S. McTaggart, A. Walker, F. Mackie, T. Kara, N. Nassar, A. Teixeira-Pinto,A. Tong, D. Johnson, J. C. Craig, and G. Wong. Quality of life of children and adolescents withchronic kidney disease: a cross-sectional study. Arch Dis Child, 104(2):134–140, 2019.

[61] M. L. Hackett, A. Teixeira-Pinto, S. Farnbach, N. Glozier, T. Skinner, D. A. Askew, G. Gee,A. Cass, and A. Brown. Getting it right: validating a culturally specific screening tool for de-pression (aphq-9) in aboriginal and torres strait islander australians. 2019.

[62] C. S. Hanson, T. Gutman, J. C. Craig, S. Bernays, G. Raman, Y. Zhang, L. J. James, A. F. Ralph,A. Ju, K. E. Manera, A. Teixeira-Pinto, A. K. Viecelli, S. I. Alexander, T. D. Blydt-Hansen,J. Dionne, S. McTaggart, M. Michael, A. Walker, S. Carter, S. E. Wenderfer, W. C. Winkelmayer,D. Bockenhauer, A. Dart, A. A. Eddy, S. L. Furth, D. S. Gipson, S. L. Goldstein, J. Groothoff,S. Samuel, A. Sinha, N. J. A. Webb, H. K. Yap, M. Zappitelli, H. Currier, and A. Tong. Iden-tifying important outcomes for young people with ckd and their caregivers: A nominal grouptechnique study. Am J Kidney Dis, 74(1):82–94, 2019.

[63] A. Ju, M. Unruh, S. N. Davison, J. Dapueto, M. A. Dew, R. Fluck, M. Germain, S. V. Jassal,G. Obrador, D. O’Donoghue, and e. al. Identifying dimensions of fatigue in haemodialysis im-portant to patients, caregivers and health professionals: An international survey. Nephrology,2019.

[64] N. G. Larkins, J. C. Craig, and A. Teixeira-Pinto. A guide to missing data for the pediatricnephrologist. Pediatr Nephrol, 34(2):223–231, 2019.

[65] N. G. Larkins, A. Teixeira-Pinto, and J. C. Craig. A narrative review of proteinuria and albumin-uria as clinical biomarkers in children. J Paediatr Child Health, 55(2):136–142, 2019.

[66] N. G. Larkins, A. Teixeira-Pinto, S. Kim, D. P. Burgner, and J. C. Craig. The population-basedprevalence of hypertension and correlates of blood pressure among australian children. PediatrNephrol, 34(6):1107–1115, 2019.

[67] W. H. Lim, D. W. Johnson, A. Teixeira-Pinto, and G. Wong. Association between duration ofdelayed graft function, acute rejection, and allograft outcome after deceased donor kidney trans-plantation. Transplantation, 103(2):412–419, 2019.

[68] Y. Liu, X. Liu, R. L. J, K. Brock, C. B.-S. T, and A. Teixeira-Pinto. Relationship between serumosteocalcin/undercarboxylated osteocalcin and type 2 diabetes: a systematic review/meta-analysis study protocol. BMJ Open, 9(3):e023918, 2019.

[69] K. E. Manera, D. W. Johnson, J. C. Craig, J. I. Shen, L. Ruiz, A. Y. Wang, T. Yip, S. K. S. Fung,M. Tong, A. Lee, Y. Cho, A. K. Viecelli, B. Sautenet, A. Teixeira-Pinto, E. A. Brown, G. Brunier,J. Dong, T. Dunning, R. Mehrotra, S. Naicker, R. Pecoits-Filho, J. Perl, M. Wilkie, and A. Tong.Patient and caregiver priorities for outcomes in peritoneal dialysis: Multinational nominal grouptechnique study. Clin J Am Soc Nephrol, 14(1):74–83, 2019.

[70] K. E. Manera, A. Tong, J. C. Craig, J. Shen, S. Jesudason, Y. Cho, B. Sautenet, A. Teixeira-Pinto,M. Howell, A. Y. Wang, E. A. Brown, G. Brunier, J. Perl, J. Dong, M. Wilkie, R. Mehrotra,R. Pecoits-Filho, S. Naicker, T. Dunning, N. Scholes-Robertson, and D. W. Johnson. An inter-national delphi survey helped develop consensus-based core outcome domains for trials in peri-toneal dialysis. Kidney Int, 96(3):699–710, 2019.

[71] G. Rennie, A. Wilkinson, A. White, M. Ruospo, A. Teixeira-Pinto, and G. Strippoli. Topicalmedical therapy and ocular perfusion pressure in open angle glaucoma: a systematic reviewand meta-analysis. Curr Med Res Opin, 35(8):1421–1431, 2019.

[72] V. M. Saglimbene, G. Wong, M. Ruospo, S. C. Palmer, K. Campbell, V. G. Larsen, P. Natale,A. Teixeira-Pinto, J. J. Carrero, P. Stenvinkel, L. Gargano, A. M. Murgo, D. W. Johnson, M. Tonelli,R. Gelfman, E. Celia, T. Ecder, A. G. Bernat, D. Del Castillo, D. Timofte, M. Torok, A. Bednarek-Skublewska, J. Dulawa, P. Stroumza, S. Hoischen, M. Hansis, E. Fabricius, C. Wollheim, J. Heg-brant, J. C. Craig, and G. F. M. Strippoli. Dietary n-3 polyunsaturated fatty acid intake and all-cause and cardiovascular mortality in adults on hemodialysis: The diet-hd multinational cohortstudy. Clin Nutr, 38(1):429–437, 2019.

[73] V. M. Saglimbene, G. Wong, M. Ruospo, S. C. Palmer, V. Garcia-Larsen, P. Natale, A. Teixeira-Pinto, K. L. Campbell, J. J. Carrero, P. Stenvinkel, L. Gargano, A. M. Murgo, D. W. Johnson,M. Tonelli, R. Gelfman, E. Celia, T. Ecder, A. G. Bernat, D. Del Castillo, D. Timofte, M. Torok,A. Bednarek-Skublewska, J. Dulawa, P. Stroumza, S. Hoischen, M. Hansis, E. Fabricius, P. Felaco,C. Wollheim, J. Hegbrant, J. C. Craig, and G. F. M. Strippoli. Fruit and vegetable intake andmortality in adults undergoing maintenance hemodialysis. Clin J Am Soc Nephrol, 14(2):250–260,2019.

[74] V. M. Saglimbene, G. Wong, A. Teixeira-Pinto, J. C. Craig, and G. F. M. Strippoli. Reply-letterto the editor-effects of omega-3 polyunsaturated fatty acid intake in patients with chronic kid-ney disease: Systematic review and meta-analysis of randomized controlled trials. Clin Nutr,38(5):2462, 2019.

[75] H. Seligman, A. Teixeira-Pinto, A. Nowbar, and D. Francis. Fragility of the bond between car-diovascular investigators and their readers. Circ Cardiovasc Qual Outcomes, 12(12):e006271, 2019.

[76] K. Shen, D. A. Vesey, R. J. Ellis, S. J. Del Vecchio, Y. Cho, A. Teixeira-Pinto, M. A. McGuckin,D. W. Johnson, and G. C. Gobe. Grp78 expression in tumor and perinephric adipose tissue is notan optimal risk stratification marker for clear cell renal cell carcinoma. PLoS One, 14(1):e0210246,2019.

[77] J. Stevenson, K. L. Campbell, M. Brown, J. Craig, K. Howard, M. Howell, R. Khalid, K. Sud,A. Teixeira-Pinto, A. Thiagalingam, A. Tong, C. Chow, and V. W. Lee. Targeted, structured textmessaging to improve dietary and lifestyle behaviours for people on maintenance haemodialysis(kidneytext): study protocol for a randomised controlled trial. BMJ Open, 9(5):e023545, 2019.

[78] van A. Zwieten, P. Caldwell, K. Howard, A. Tong, J. Craig, S. Alexander, M. Howell, A. Teixeira-Pinto, C. Hawley, S. Jesudason, A. Walker, F. Mackie, S. Kennedy, S. McTaggart, H. McCarthy,S. Carter, S. Kim, S. Crafter, R. Woodleigh, G. Chandana, and G. Wong. Nav-kids trial: protocolfor a multi-centre, staggered randomised controlled trial of a patient navigator intervention inchildren with chronic kidney disease. BMC Nephrology, (in press), 2019.

[79] van A. Zwieten, G. Wong, M. Ruospo, S. C. Palmer, A. Teixeira-Pinto, M. R. Barulli, A. Iurillo,V. Saglimbene, P. Natale, L. Gargano, M. Murgo, C. T. Loy, R. Tortelli, J. C. Craig, D. W. Johnson,M. Tonelli, J. Hegbrant, C. Wollheim, G. Logroscino, G. F. M. Strippoli, and C.-H. S. Investiga-tors. Associations of cognitive function and education level with all-cause mortality in adults onhemodialysis: Findings from the cognitive-hd study. Am J Kidney Dis, 74(4):452–462, 2019.

[80] G. Wong, R. L. Hope, K. Howard, J. R. Chapman, A. Castells, S. D. Roger, M. J. Bourke,P. Macaskill, R. Turner, G. Williams, W. H. Lim, C. E. Lok, F. Diekman, N. Cross, S. Sen, R. D. M.Allen, S. J. Chadban, C. A. Pollock, A. Tong, A. Teixeira-Pinto, J. Y. H. Yang, N. Williams, E. Au,A. Kieu, L. James, and J. C. Craig. Authors’ reply. J Am Soc Nephrol, 30(11):2276–2277, 2019.

[81] G. Wong, R. L. Hope, K. Howard, J. R. Chapman, A. Castells, S. D. Roger, M. J. Bourke,P. Macaskill, R. Turner, G. Williams, W. H. Lim, C. E. Lok, F. Diekmann, N. B. Cross, S. Sen,R. D. M. Allen, S. J. Chadban, C. A. Pollock, A. Tong, A. Teixeira-Pinto, J. Y. H. Yang, N. Williams,E. H. K. Au, A. Kieu, L. James, and J. C. Craig. One-time fecal immunochemical screening foradvanced colorectal neoplasia in patients with ckd (detect study). J Am Soc Nephrol, 30(6):1061–1072, 2019.

[82] L. Bacelar-Nicolau, T. Rodrigues, E. Fernandes, M. F. Lobo, C. F. Nisa, V. Azzone, A. Teixeira-Pinto, A. Costa-Pereira, S.-L. T. Normand, and J. Pereira Miguel. Picturing inequities for healthimpact assessment: linked electronic records, mortality and regional disparities in portugal. Im-pact Assessment and Project Appraisal, 36(1):90–104, 2018.

[83] K. Chen, M. Didsbury, van A. Zwieten, M. Howell, S. Kim, A. Tong, K. Howard, N. Nassar,B. Barton, S. Lah, J. Lorenzo, G. Strippoli, S. Palmer, A. Teixeira-Pinto, F. Mackie, S. McTaggart,A. Walker, T. Kara, J. C. Craig, and G. Wong. Neurocognitive and educational outcomes in chil-dren and adolescents with ckd: A systematic review and meta-analysis. Clin J Am Soc Nephrol,13(3):387–397, 2018.

[84] S. De, A. Teixeira-Pinto, J. R. Sewell, and P. H. Caldwell. Prevalence, patient and consultationcharacteristics of enuresis in australian paediatric practice. J Paediatr Child Health, 54(6):620–624,2018.

[85] A. Francis, D. W. Johnson, J. Craig, A. Teixeira-Pinto, and G. Wong. Post-transplant lymphopro-liferative disease may be an adverse risk factor for patient survival but not graft loss in kidneytransplant recipients. Kidney Int, 94(4):809–817, 2018.

[86] A. Francis, D. W. Johnson, A. Teixeira-Pinto, J. C. Craig, and G. Wong. Incidence and predictorsof post-transplant lymphoproliferative disease after kidney transplantation during adulthoodand childhood: a registry study. Nephrol Dial Transplant, 33(5):881–889, 2018.

[87] C. S. Hanson, J. R. Chapman, J. S. Gill, J. Kanellis, G. Wong, J. C. Craig, A. Teixeira-Pinto, S. J.Chadban, A. X. Garg, A. F. Ralph, J. Pinter, J. R. Lewis, and A. Tong. Identifying outcomes thatare important to living kidney donors: A nominal group technique study. Clin J Am Soc Nephrol,13(6):916–926, 2018.

[88] A. Kelly, A. Tong, K. Tymms, L. March, J. C. Craig, M. De Vera, V. Evans, G. Hassett, K. Toupin-April, van den B. Bemt, A. Teixeira-Pinto, R. Alten, S. J. Bartlett, W. Campbell, T. Dawson,M. Gill, R. Hebing, A. Meara, R. Nieuwlaat, Y. Shaw, J. A. Singh, M. Suarez-Almazor, D. Sump-ton, P. Wong, R. Christensen, D. Beaton, de M. Wit, P. Tugwell, and O. M.-A. Group. Outcomemeasures in rheumatology - interventions for medication adherence (omeract-adherence) coredomain set for trials of interventions for medication adherence in rheumatology: 5 phase studyprotocol. Trials, 19(1):204, 2018.

[89] N. G. Larkins, A. Teixeira-Pinto, and J. C. Craig. The prevalence and predictors of hypertensionin a national survey of australian children. Blood Press, 27(1):41–47, 2018.

[90] S. C. Palmer, M. Ruospo, A. Teixeira-Pinto, J. C. Craig, P. Macaskill, and G. F. M. Strippoli. Thevalidity of drug effects on proteinuria, albuminuria, serum creatinine, and estimated gfr as sur-rogate end points for eskd: A systematic review. Am J Kidney Dis, 72(6):779–789, 2018.

[91] V. M. Saglimbene, G. Wong, J. C. Craig, M. Ruospo, S. C. Palmer, K. Campbell, V. Garcia-Larsen,P. Natale, A. Teixeira-Pinto, J. J. Carrero, P. Stenvinkel, L. Gargano, A. M. Murgo, D. W. Johnson,M. Tonelli, R. Gelfman, E. Celia, T. Ecder, A. G. Bernat, D. Del Castillo, D. Timofte, M. Torok,A. Bednarek-Skublewska, J. Dulawa, P. Stroumza, S. Hoischen, M. Hansis, E. Fabricius, P. Felaco,C. Wollheim, J. Hegbrant, and G. F. M. Strippoli. The association of mediterranean and dashdiets with mortality in adults on hemodialysis: The diet-hd multinational cohort study. J Am SocNephrol, 29(6):1741–1751, 2018.

[92] A. Tong, B. Manns, A. Y. M. Wang, B. Hemmelgarn, D. C. Wheeler, J. Gill, P. Tugwell, R. Pecoits-Filho, S. Crowe, T. Harris, W. Van Biesen, W. C. Winkelmayer, A. Levin, A. Thompson,V. Perkovic, A. Ju, T. Gutman, A. Bernier-Jean, A. K. Viecelli, E. O’Lone, J. Shen, M. A. Josephson,Y. Cho, D. W. Johnson, B. Sautenet, M. Tonelli, J. C. Craig, and S. I. W. Investigators. Implement-ing core outcomes in kidney disease: report of the standardized outcomes in nephrology (song)implementation workshop. Kidney Int, 94(6):1053–1068, 2018.

[93] van A. Zwieten, V. Saglimbene, A. Teixeira-Pinto, M. Howell, K. Howard, J. C. Craig, andG. Wong. The impact of age on income-related health status inequalities from birth to ado-lescence: A systematic review with cross-country comparisons. J Pediatr, 203:380–390 e14, 2018.

[94] G. Wong, A. Sharma, A. Teixeira-Pinto, and M. Howell. Systematic reviews and meta-analysesin transplantation: Challenges and pitfalls? Transplantation, 102(9):1415–1418, 2018.

[95] P. J. Allen, S. J. Chadban, J. C. Craig, W. H. Lim, R. D. M. Allen, P. A. Clayton, A. Teixeira-Pinto,and G. Wong. The authors reply. Kidney Int, 92(5):1291, 2017.

[96] P. J. Allen, S. J. Chadban, J. C. Craig, W. H. Lim, R. D. M. Allen, P. A. Clayton, A. Teixeira-Pinto, and G. Wong. Recurrent glomerulonephritis after kidney transplantation: risk factors andallograft outcomes. Kidney Int, 92(2):461–469, 2017.

[97] Y. Cho, B. Sautenet, G. Rangan, J. C. Craig, A. C. M. Ong, A. Chapman, C. Ahn, D. Chen,H. Coolican, J. T. Kao, R. Gansevoort, R. Perrone, T. Harris, V. Torres, Y. Pei, P. G. Kerr, J. Ryan,T. Gutman, M. Howell, A. Ju, K. E. Manera, A. Teixeira-Pinto, L. A. Hamiwka, and A. Tong.Standardised outcomes in nephrology-polycystic kidney disease (song-pkd): study protocol forestablishing a core outcome set in polycystic kidney disease. Trials, 18(1):560, 2017.

[98] F. He, A. Teixeira-Pinto, and J. Harezlak. Autoregressive and cross-lagged model for bivariatenon-commensurate outcomes. Stat Med, 36(19):3110–3120, 2017.

[99] A. Krishnan, A. Teixeira-Pinto, D. Chan, A. Chakera, G. Dogra, N. Boudville, A. Irish, K. Morgan,J. Phillips, G. Wong, and W. H. Lim. Impact of early conversion from cyclosporin to everolimuson left ventricular mass index: A randomized controlled trial. Clin Transplant, 31(10), 2017.

[100] N. Larkins, A. Teixeira-Pinto, E. Banks, H. Gunasekera, A. Cass, J. Kearnes, J. C. Craig, andS. investigators. Blood pressure among australian aboriginal children. J Hypertens, 35(9):1801–1807, 2017.

[101] N. Larkins, A. Teixeira-Pinto, and J. Craig. The population-based prevalence of albuminuria inchildren. Pediatr Nephrol, 32(12):2303–2309, 2017.

[102] M. F. Lobo, V. Azzone, L. F. Azevedo, B. Melica, A. Freitas, L. Bacelar-Nicolau, F. N. Rocha-Goncalves, C. Nisa, A. Teixeira-Pinto, J. Pereira-Miguel, F. S. Resnic, A. Costa-Pereira, and S. L.Normand. A comparison of in-hospital acute myocardial infarction management between por-tugal and the united states: 2000-2010. Int J Qual Health Care, 29(5):669–678, 2017.

[103] M. F. Lobo, V. Azzone, F. S. Resnic, B. Melica, A. Teixeira-Pinto, L. F. Azevedo, A. Freitas, C. Nisa,L. Bacelar-Nicolau, F. N. Rocha-Goncalves, J. Pereira-Miguel, A. Costa-Pereira, and S. L. Nor-mand. The atlantic divide in coronary heart disease: Epidemiology and patient care in the usand portugal. Rev Port Cardiol, 36(9):583–593, 2017.

[104] C. M. Mincham, G. Wong, A. Teixeira-Pinto, S. Kennedy, S. Alexander, N. Larkins, and W. H.Lim. Induction therapy, rejection, and graft outcomes in pediatric and adolescent kidney trans-plant recipients. Transplantation, 101(9):2146–2151, 2017.

[105] A. Teixeira-Pinto. When bayes comes to town. Circ Cardiovasc Qual Outcomes, 10(8), 2017.

[106] G. Wong, A. Teixeira-Pinto, J. R. Chapman, J. C. Craig, H. Pleass, S. McDonald, and W. H. Lim.The impact of total ischemic time, donor age and the pathway of donor death on graft outcomesafter deceased donor kidney transplantation. Transplantation, 101(6):1152–1158, 2017.

[107] Q. Xia, A. Teixeira-Pinto, L. A. Forgione, E. W. Wiewel, S. L. Braunstein, and L. V. Torian. Es-timated hiv incidence in the united states, 2003-2010. J Acquir Immune Defic Syndr, 74(1):10–14,2017.

[108] S. V. Badve, S. C. Palmer, G. F. M. Strippoli, M. A. Roberts, A. Teixeira-Pinto, N. Boudville,A. Cass, C. M. Hawley, S. S. Hiremath, E. M. Pascoe, V. Perkovic, G. A. Whalley, J. C. Craig, andD. W. Johnson. The validity of left ventricular mass as a surrogate end point for all-cause andcardiovascular mortality outcomes in people with ckd: A systematic review and meta-analysis.Am J Kidney Dis, 68(4):554–563, 2016.

[109] H. Brodaty, M. H. Connors, C. Loy, A. Teixeira-Pinto, N. Stocks, J. Gunn, K. E. Mate, and C. D.Pond. Screening for dementia in primary care: A comparison of the gpcog and the mmse. DementGeriatr Cogn Disord, 42(5-6):323–330, 2016.

[110] P. H. Caldwell, P. Sureshkumar, M. I. Kerr, S. Hamilton, A. Teixeira-Pinto, P. Macaskill, and J. C.Craig. A randomised controlled trial of a code-word enuresis alarm. Arch Dis Child, 101(4):326–31, 2016.

[111] J. M. Furtado, D. L. Esposito, T. M. Klein, T. Teixeira-Pinto, and da B. A. Fonseca. Uveitis associ-ated with zika virus infection. N Engl J Med, 375(4):394–6, 2016.

[112] M. L. Hackett, S. Farnbach, N. Glozier, T. Skinner, A. Teixeira-Pinto, D. Askew, G. Gee, A. Cass,and A. Brown. Getting it right: study protocol to determine the diagnostic accuracy of aculturally-specific measure to screen for depression in aboriginal and/or torres strait islanderpeople. BMJ Open, 6(12):e015009, 2016.

[113] S. McKinn, C. Bonner, J. Jansen, A. Teixeira-Pinto, M. So, L. Irwig, J. Doust, P. Glasziou, andK. McCaffery. Factors influencing general practitioners’ decisions about cardiovascular diseaserisk reassessment: findings from experimental and interview studies. BMC Fam Pract, 17:107,2016.

[114] A. Mendes, A. Goncalves, N. Vila-Cha, M. Calejo, I. Moreira, J. Fernandes, J. Damasio,A. Teixeira-Pinto, P. Krack, A. B. Lima, and S. Cavaco. Statistical models of parkinson’s diseaseprogression: Predictive validity in a 3-year follow-up. J Parkinsons Dis, 6(4):793–804, 2016.

[115] L. Orwelius, A. Teixeira-Pinto, C. Lobo, A. Costa-Pereira, and C. Granja. The role of memories onhealth-related quality of life after intensive care unit care: an unforgettable controversy? PatientRelat Outcome Meas, 7:63–71, 2016.

[116] N. Sousa, O. Sousa, L. L. Santos, R. Henrique, M. R. Teixeira, M. Dinis-Ribeiro, and A. Teixeira-Pinto. Lapatinib-capecitabine versus capecitabine alone as radiosensitizers in ras wild-type re-sectable rectal cancer, an adaptive randomized phase ii trial (larrc trial): study protocol for arandomized controlled trial. Trials, 17(1):459, 2016.

[117] J. S. Bagia, A. Chai, R. Chou, C. Chu, J. Rouse, E. Sinclair, L. Vonthethoff, and A. Teixeira-Pinto.Prospective diagnostic test accuracy comparison of computed tomography during arterial por-tography and primovist magnetic resonance imaging in the pre-operative assessment of colorec-tal cancer liver metastases. HPB (Oxford), 17(10):927–35, 2015.

[118] C. Bonner, J. Jansen, B. R. Newell, L. Irwig, A. Teixeira-Pinto, P. Glasziou, J. Doust, S. McKinn,and K. McCaffery. Is the ”heart age” concept helpful or harmful compared to absolute cardio-vascular disease risk? an experimental study. Med Decis Making, 35(8):967–78, 2015.

[119] S. Cavaco, S. W. Anderson, K. H. Chen, A. Teixeira-Pinto, and H. Damasio. Parietal damageimpairs learning of a visuomotor tracking skill. Neuropsychologia, 79(Pt A):106–12, 2015.

[120] S. Cavaco, A. Goncalves, A. Mendes, N. Vila-Cha, I. Moreira, J. Fernandes, J. Damasio,A. Teixeira-Pinto, and A. Bastos Lima. Abnormal olfaction in parkinson’s disease is relatedto faster disease progression. Behav Neurol, 2015:976589, 2015.

[121] S. Cavaco, A. Goncalves, C. Pinto, E. Almeida, F. Gomes, I. Moreira, J. Fernandes, andA. Teixeira-Pinto. Auditory verbal learning test in a large nonclinical portuguese population.Appl Neuropsychol Adult, 22(5):321–31, 2015.

[122] S. De, G. J. Williams, A. Teixeira-Pinto, P. Macaskill, M. McCaskill, D. Isaacs, and J. C. Craig.Lack of accuracy of body temperature for detecting serious bacterial infection in febrile episodes.Pediatr Infect Dis J, 34(9):940–4, 2015.

[123] I. Martins, P. Carvalho, de M. G. Vries, A. Teixeira-Pinto, S. P. Wilson, B. H. Westerink, andI. Tavares. Gaba acting on gabab receptors located in a medullary pain facilitatory area enhancesnociceptive behaviors evoked by intraplantar formalin injection. Pain, 156(8):1555–65, 2015.

[124] I. Martins, P. Carvalho, de M. G. Vries, A. Teixeira-Pinto, S. P. Wilson, B. H. Westerink, andI. Tavares. Increased noradrenergic neurotransmission to a pain facilitatory area of the brain isimplicated in facilitation of chronic pain. Anesthesiology, 123(3):642–53, 2015.

[125] A. Martins Da Silva, S. Cavaco, I. Moreira, A. Bettencourt, E. Santos, C. Pinto, A. Goncalves,E. Coutinho, R. Samoes, C. C. Dias, A. Teixeira-Pinto, B. M. Da Silva, and X. Montalban. Cog-nitive reserve in multiple sclerosis: Protective effects of education. Mult Scler, 21(10):1312–21,2015.

[126] K. McCaffery, B. Nickel, R. Moynihan, J. Hersch, A. Teixeira-Pinto, L. Irwig, and A. Barratt.How different terminology for ductal carcinoma in situ impacts women’s concern and treat-ment preferences: a randomised comparison within a national community survey. BMJ Open,5(11):e008094, 2015.

[127] A. Mendes, A. Goncalves, N. Vila-Cha, I. Moreira, J. Fernandes, J. Damasio, A. Teixeira-Pinto,R. Taipa, A. B. Lima, and S. Cavaco. Appendectomy may delay parkinson’s disease onset. MovDisord, 30(10):1404–7, 2015.

[128] R. Oliveira and A. Teixeira-Pinto. Analyzing multiple outcomes: Is it really worth the use ofmultivariate linear regression? Journal of Biometrics and Biostatistics, 6(4):256, 2015.

[129] S. C. Palmer, A. Teixeira-Pinto, V. Saglimbene, J. C. Craig, P. Macaskill, M. Tonelli, de G. Berardis,M. Ruospo, and G. F. Strippoli. Association of drug effects on serum parathyroid hormone, phos-phorus, and calcium levels with mortality in ckd: A meta-analysis. Am J Kidney Dis, 66(6):962–71,2015.

[130] M. L. Bell, A. Teixeira-Pinto, J. E. McKenzie, and J. Olivier. A myriad of methods: calculated sam-ple size for two proportions was dependent on the choice of sample size formula and software.J Clin Epidemiol, 67(5):601–5, 2014.

[131] J. Jansen, C. Bonner, S. McKinn, L. Irwig, P. Glasziou, J. Doust, A. Teixeira-Pinto, A. Hayen,R. Turner, and K. McCaffery. General practitioners’ use of absolute risk versus individual riskfactors in cardiovascular disease prevention: an experimental study. BMJ Open, 4(5):e004812,2014.

[132] F. X. Liu, A. Ghaffari, H. Dhatt, V. Kumar, C. Balsera, E. Wallace, Q. Khairullah, B. Lesher, X. Gao,H. Henderson, P. LaFleur, E. M. Delgado, M. M. Alvarez, J. Hartley, M. McClernon, S. Wal-ton, and S. Guest. Economic evaluation of urgent-start peritoneal dialysis versus urgent-starthemodialysis in the united states. Medicine (Baltimore), 93(28):e293, 2014.

[133] A. Teixeira-Pinto. Medical statistics in clinical and epidemiological research by marit b. veierødstian lydersen and petter laake, gyldendal norsk forlag, oslo, 2012. no. of pages: 714. price: 575norwegian kroner. isbn: 978-82-05-39959-4. Statistics in Medicine, 33(9):1619–1620, 2014.

[134] P. D. Xavier, G. L. Lema, M. C. Magalhaes, A. Teixeira-Pinto, S. Sampaio-Norton, S. Gaiao,T. Guimaraes, and J. G. Oliveira. Flow cytometry assessment of graft-infiltrating lymphocytescan accurately identify acute rejection in kidney transplants. Clin Transplant, 28(2):177–83, 2014.

[135] T. Cardoso, A. Teixeira-Pinto, P. P. Rodrigues, I. Aragao, A. Costa-Pereira, and A. E. Sarmento.Predisposition, insult/infection, response and organ dysfunction (piro): a pilot clinical stagingsystem for hospital mortality in patients with infection. PLoS One, 8(7):e70806, 2013.

[136] S. Cavaco, A. Goncalves, C. Pinto, E. Almeida, F. Gomes, I. Moreira, J. Fernandes, andA. Teixeira-Pinto. Semantic fluency and phonemic fluency: regression-based norms for the por-tuguese population. Arch Clin Neuropsychol, 28(3):262–71, 2013.

[137] S. Cavaco, A. Goncalves, C. Pinto, E. Almeida, F. Gomes, I. Moreira, J. Fernandes, andA. Teixeira-Pinto. Trail making test: regression-based norms for the portuguese population.Arch Clin Neuropsychol, 28(2):189–98, 2013.

[138] F. Cunha, T. Mota, A. Teixeira-Pinto, L. Carvalho, J. Estrada, A. Marques, A. Costa-Pereira, andL. Almeida-Santos. Factors associated with health-related quality of life changes in survivors topediatric intensive care. Pediatr Crit Care Med, 14(1):e8–15, 2013.

[139] F. Cunha and A. Teixeira-Pinto. Back to the picu: who is at risk and outcome of unplannedreadmissions. Crit Care Med, 41(12):2831–2, 2013.

[140] C. Granja, P. Povoa, C. Lobo, A. Teixeira-Pinto, A. Carneiro, and A. Costa-Pereira. The predispo-sition, infection, response and organ failure (piro) sepsis classification system: results of hospitalmortality using a novel concept and methodological approach. PLoS One, 8(1):e53885, 2013.

[141] I. Martins, de M. G. Vries, A. Teixeira-Pinto, J. Fadel, S. P. Wilson, B. H. Westerink, and I. Tavares.Noradrenaline increases pain facilitation from the brain during inflammatory pain. Neurophar-macology, 71:299–307, 2013.

[142] L. Orwelius, C. Lobo, A. Teixeira Pinto, A. Carneiro, A. Costa-Pereira, and C. Granja. Sepsispatients do not differ in health-related quality of life compared with other icu patients. ActaAnaesthesiol Scand, 57(9):1201–5, 2013.

[143] J. M. Pereira, A. Teixeira-Pinto, C. Basilio, C. Sousa-Dias, P. Mergulhao, and J. A. Paiva. Can wepredict pneumococcal bacteremia in patients with severe community-acquired pneumonia? JCrit Care, 28(6):970–4, 2013.

[144] P. Bartolucci, C. Brugnara, A. Teixeira-Pinto, S. Pissard, K. Moradkhani, H. Jouault, and F. Galac-teros. Erythrocyte density in sickle cell syndromes is associated with specific clinical manifesta-tions and hemolysis. Blood, 120(15):3136–41, 2012.

[145] S. Cavaco, Martins da A. Silva, E. Santos, E. Coutinho, A. Marinho, I. Moreira, A. Goncalves,C. Pinto, A. Teixeira-Pinto, and C. Vasconcelos. Are cognitive and olfactory dysfunctions in neu-ropsychiatric lupus erythematosus dependent on anxiety or depression? J Rheumatol, 39(4):770–6, 2012.

[146] V. Certal, E. Catumbela, J. C. Winck, I. Azevedo, A. Teixeira-Pinto, and A. Costa-Pereira. Clinicalassessment of pediatric obstructive sleep apnea: a systematic review and meta-analysis. Laryn-goscope, 122(9):2105–14, 2012.

[147] F. Cunha, L. Almeida-Santos, A. Teixeira-Pinto, F. Neves, D. Barata, and A. Costa-Pereira.Health-related quality of life of pediatric intensive care survivors. J Pediatr (Rio J), 88(1):25–32,2012.

[148] L. M. Ferreira-Pinto, F. Rocha-Goncalves, and A. Teixeira-Pinto. An ecological study on thegeographic patterns of ischaemic heart disease in portugal and its association with demography,economic factors and health resources distribution. BMJ Open, 2(4), 2012.

[149] A. Freitas, T. Silva-Costa, F. Lopes, I. Garcia-Lema, A. Teixeira-Pinto, P. Brazdil, and A. Costa-Pereira. Factors influencing hospital high length of stay outliers. BMC Health Serv Res, 12:265,2012.

[150] P. Povoa, A. M. Teixeira-Pinto, A. H. Carneiro, and S. Portuguese Community-Acquired SepsisStudy Group. C-reactive protein, an early marker of community-acquired sepsis resolution: amulti-center prospective observational study. Crit Care, 15(4):R169, 2011.

[151] A. Teixeira-Pinto and L. Mauri. Statistical analysis of noncommensurate multiple outcomes. CircCardiovasc Qual Outcomes, 4(6):650–6, 2011.

[152] A. Teixeira-Pinto and S. L. Normand. Missing data in regression models for non-commensuratemultiple outcomes. Revstat Stat J, 9(1):37–55, 2011.

[153] T. Cardoso, A. H. Carneiro, O. Ribeiro, A. Teixeira-Pinto, and A. Costa-Pereira. Reducing mortal-ity in severe sepsis with the implementation of a core 6-hour bundle: results from the portuguesecommunity-acquired sepsis study (saciuci study). Crit Care, 14(3):R83, 2010.

[154] A. P. Fontes-Sousa, C. Moura, C. S. Carneiro, A. Teixeira-Pinto, J. C. Areias, and A. F. Leite-Moreira. Echocardiographic evaluation including tissue doppler imaging in new zealand whiterabbits sedated with ketamine and midazolam. Vet J, 181(3):326–31, 2009.

[155] C. Moura, A. P. Fontes-Sousa, A. Teixeira-Pinto, J. C. Areias, and A. F. Leite-Moreira. Agreementbetween echocardiographic techniques in assessment of the left ventricular myocardial perfor-mance index in rabbits. Am J Vet Res, 70(4):464–71, 2009.

[156] A. Teixeira-Pinto and S. L. Normand. Comments on ’the bugs project: Evolution, critique, andfuture directions’. Stat Med, 28(25):3075–8, 2009.

[157] A. Teixeira-Pinto and S. L. Normand. Correlated bivariate continuous and binary outcomes:issues and applications. Stat Med, 28(13):1753–73, 2009.

[158] A. Teixeira-Pinto, J. Siddique, R. Gibbons, and S. L. Normand. Statistical approaches to modelingmultiple outcomes in psychiatric studies. Psychiatr Ann, 39(7):729–735, 2009.

[159] M. Neovius, A. Teixeira-Pinto, and F. Rasmussen. Shift in the composition of obesity in youngadult men in sweden over a third of a century. Int J Obes (Lond), 32(5):832–6, 2008.

[160] A. Teixeira-Pinto and S. L. Normand. Statistical methodology for classifying units on the basisof multiple-related measures. Stat Med, 27(9):1329–50, 2008.

[161] S. Borzoei, M. Neovius, B. Barkeling, A. Teixeira-Pinto, and S. Rossner. A comparison of effectsof fish and beef protein on satiety in normal weight men. Eur J Clin Nutr, 60(7):897–902, 2006.

[162] S. Guerra, A. Teixeira-Pinto, J. C. Ribeiro, A. Ascensao, J. Magalhaes, L. B. Andersen, J. A. Duarte,and J. Mota. Relationship between physical activity and obesity in children and adolescents. JSports Med Phys Fitness, 46(1):79–83, 2006.

[163] D. K. Kelleher, P. Laussen, A. Teixeira-Pinto, and C. Duggan. Growth and correlates of nutri-tional status among infants with hypoplastic left heart syndrome (hlhs) after stage 1 norwoodprocedure. Nutrition, 22(3):237–44, 2006.

[164] H. Antunes, S. Goncalves, A. Teixeira-Pinto, A. Costa-Pereira, A. Tojo-Sierra, and A. Aguiar.[iron deficiency anemia in infants. preliminary development results at five years]. Acta Med Port,18(4):261–6, 2005.

[165] C. Duggan, A. R. Stark, N. Auestad, S. Collier, J. Fulhan, K. Gura, S. Utter, A. Teixeira-Pinto,K. Donovan, and D. Lund. Glutamine supplementation in infants with gastrointestinal disease:a randomized, placebo-controlled pilot trial. Nutrition, 20(9):752–6, 2004.

[166] J. Estevao-Costa, J. A. Dias, M. Campos, E. Trindade, A. Teixeira-Pinto, and J. L. Carvalho. Canesophageal ph monitoring predict delayed gastric emptying? J Pediatr Surg, 39(10):1537–40,2004.

[167] J. C. Ribeiro, S. Guerra, J. Oliveira, A. Teixeira-Pinto, J. W. Twisk, J. A. Duarte, and J. Mota. Physi-cal activity and biological risk factors clustering in pediatric population. Prev Med, 39(3):596–601,2004.

[168] J. C. Winck, M. Vitacca, A. Morais, L. Barbano, R. Porta, A. Teixeira-Pinto, and N. Ambrosino.Tolerance and physiologic effects of nocturnal mask pressure support vs proportional assist ven-tilation in chronic ventilatory failure. Chest, 126(2):382–8, 2004.

[169] S. Guerra, J. Oliveira, J. C. Ribeiro, A. Teixeira-Pinto, J. Duarte, and J. Mota. Relationship be-tween regular physical activity and aggregated biological risk factors in cardiovascular diseasesin children and adolescents. Revista Brasileira de Saude Materno Infantil, 3(1):9–15, 2003.

[170] S. Guerra, A. T. Pinto, J. Ribeiro, J. Oliveira, J. Duarte, and J. Mota. Stability of risk factors forcardiovascular diseases in portuguese children and adolescents from the porto area. RevistaPortuguesa de Cardiologia, 22(2):167–182, 2003.

[171] S. Guerra, J. C. C. Ribeiro, J. Oliveira, A. Teixeira-Pinto, J. W. R. Twisk, J. Duarte, and J. Mota.One-year stability of cardiovascular diseases risk factors in portuguese youngsters. PediatricExercise Science, 15(4):428–439, 2003.

[172] O. Levy, A. Teixeira-Pinto, M. L. White, S. F. Carroll, L. Lehmann, D. Wypij, and E. Guinan.Endotoxemia and elevation of lipopolysaccharide-binding protein after hematopoietic stem celltransplantation. Pediatr Infect Dis J, 22(11):978–81, 2003.

[173] J. Ribeiro, S. Guerra, A. T. Pinto, J. Duarte, and J. Mota. Prevalencia de excesso de peso e deobesidade numa populaescolar da area do grande porto, de acordo com diferentes pontos decorte do indice de massa corporal. Acta Pediatr Port, 34(1):21–4, 2003.

[174] J. Ribeiro, S. Guerra, A. Pinto, J. Oliveira, J. Duarte, and J. Mota. Overweight and obesity inchildren and adolescents: relationship with blood pressure, and physical activity. Annals ofhuman biology, 30(2):203–213, 2003.

[175] H. Antunes, S. Goncalves, A. Teixeira-Pinto, and A. Costa-Pereira. [developmental delay inchildren with iron deficiency anemia. can this be reversed by iron therapy?]. Acta Med Port,15(1):1–4, 2002.

[176] C. Granja, G. Cabral, A. T. Pinto, and A. Costa-Pereira. Quality of life 6-months after cardiacarrest. Resuscitation, 55(1):37–44, 2002.

[177] C. Granja, A. Teixeira-Pinto, and A. Costa-Pereira. Quality of life after intensive care–evaluationwith eq-5d questionnaire. Intensive Care Med, 28(7):898–907, 2002.

[178] A. Guerra, C. Rego, D. Silva, P. Rodrigues, Z. Silva, and L. Breitendfield. Blood pressure andgenetic and biological markers in a pediatric population. Revista Portuguesa de Cardiologia, 1:23–36, 2002.

[179] J. Mota, S. Guerra, C. Leandro, A. Teixeira-Pinto, J. C. Ribeiro, and J. Duarte. Association ofmaturation, sex, and body fat in cardiorespiratory fitness. American Journal of Human Biology,14(6):707–712, 2002.

[180] C. Granja, G. Cabral, L. Guerreiro, A. Vieira, and A. T. Pinto. Quality of life after cardiac arrest -evaluation with eq-5d. Critical Care, 5(1):P169, 2001.

[181] C. Granja, A. Teixeira-Pinto, and A. Costa-Pereira. Attitudes towards do-not-resuscitate de-cisions: differences among health professionals in a portuguese hospital. Intensive Care Med,27(3):555–8, 2001.

[182] M. D. Marques, A. Teixeira-Pinto, da A. Costa-Pereira, and H. M. Eriksen. Prevalence and de-terminants of periodontal disease in portuguese adults: results from a multifactorial approach.Acta Odontol Scand, 58(5):201–6, 2000.

[183] L. F. Azevedo, L. F. Salgueiro, R. Claro, A. Teixeira-Pinto, and A. Costa-Pereira. Diet and gastriccancer in portugal–a multivariate model. Eur J Cancer Prev, 8(1):41–8, 1999.

[184] M. E. Macedo, M. J. Lima, M. Pizarro, A. T. Pinto, A. Pereira, and de A. F. Freitas. [longitudinalstudy of arterial pressure in youngsters and young adults]. Rev Port Cardiol, 17(2):197–200, 1998.

[185] M. E. Macedo, A. T. Pinto, M. Pizarro, C. Marujo, A. Pereira, and de A. F. Freitas. [familialaggregation of blood pressure over 17 years in children and young adults]. Arch Mal Coeur Vaiss,91(8):1087–9, 1998.

[186] M. E. Macedo, M. Pizarro, M. J. Lima, C. Marujo, A. T. Pinto, A. Pereira, D. Trigueiros, andde A. F. Freitas. [tracking indices of the blood pressure in a longitudinal study in infants andadolescents]. Rev Port Cardiol, 17(3):243–9, 1998.

[187] A. Teixeira-Pinto and A. Costa-Pereira. Computer assisted learning vs traditional teaching: be-liefes and attitudes of medical students. Educacao Medica, 9:69–74, 1998.

[188] M. E. Macedo, M. J. Lima, M. Pizarro, D. Trigueiros, L. Lopes, A. T. Pinto, A. Pereira, and de A. F.Freitas. [blood pressure in a population of youngsters and adults observed after 17 years]. RevPort Cardiol, 16(11):887–90, 1997.

Books and chapters[1] A. Teixeira-Pinto and J. Harezlak. Factorization and latent variable models for joint analysis of binary

and continuous outcomes, pages 81–91. Chapman and Hall/CRC, 2013.

[2] S. Cavaco and A. Teixeira-Pinto. DRS-2 — Escala de Avaliacao da Demencia – 2. CEGOC-TEA,portuguese version edition, 2011.

Abstracts in peer-reviewed journals and proceedings[1] E. Au, J. Chapman, A. Teixeira-Pinto, J. Craig, and G. Wong. Exposure to a functioning kidney

transplant and cancer risks. In NEPHROLOGY, volume 23, pages 20–20. WILEY 111 RIVER ST,HOBOKEN 07030-5774, NJ USA, 2018.

[2] A. Bernier-Jean, J. Lewis, J. Craig, J. Hodgson, W. Lim, R. Prince, A. Teixeira-Pinto, and G. Wong.Dietary plant and animal protein intake and the decline in estimated glomerular filtration rateamong elderly women: A 10-year longitudinal cohort study. In NEPHROLOGY, volume 23, pages24–24. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 2018.

[3] N. Larkins, A. Teixeira-Pinto, and J. Craig. The prevalence and predictors of hypertension in anational survey of australian children (vol 27, pg 41, 2018). BLOOD PRESSURE, 27(3):183–183,2018.

[4] C. Logeman, Y. Cho, B. Sautenet, G. Rangan, T. Gutman, J. Craig, A. Ong, A. Chapman, C. Ahn,H. Coolican, et al. Patient and caregiver beliefs, attitudes and perspectives on genetic screeningand testing for autosomal polycystic kidney disease. In NEPHROLOGY, volume 23, pages 88–88.WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 2018.

[5] K. Manera, D. Johnson, J. Craig, J. Shen, A. Wang, T. Yip, S. Fung, M. Tong, Y. Cho, A. Viecelli,et al. Fp495 patient and caregiver priorities for outcomes in peritoneal dialysis: An internationalnominal group study. Nephrology Dialysis Transplantation, 33(suppl 1):i205–i205, 2018.

[6] A. Van Zwieten, G. Wong, M. Ruospo, S. Palmer, A. Teixeira-Pinto, M. Barulli, A. Iurillo,V. Saglimbene, P. Natale, L. Gargano, et al. Associations of cognitive function and educationallevel with all-cause mortality in adults on haemodialysis: The cognitive-hd cohort study. In

NEPHROLOGY, volume 23, pages 12–12. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA,2018.

[7] P. J. Allen, S. J. Chadban, J. C. Craig, W. H. Lim, R. D. Allen, P. A. Clayton, A. Teixeira-Pinto, andG. Wong. Recurrent glomerular diseases after transplantation: more detail for better understand-ing reply. KIDNEY INTERNATIONAL, 92(5):1291–1291, 2017.

[8] E. Au, J. Chapman, J. Craig, W. Lim, A. Teixeira-Pinto, S. Ullah, S. McDonald, and G. Wong. Over-all and site specific cancer mortality in patients on renal replacement therapy. In NEPHROLOGY,volume 22, pages 9–9. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 2017.

[9] M. Didsbury, A. Van Zwieten, K. Chen, L. James, A. Francis, S. Kim, G. Williams, K. Howard,S. Mctaggart, A. Walker, et al. Socioeconomic status and health in children and adolescents withchronic kidney disease-the kids with ckd study (kcad). In NEPHROLOGY, volume 22, pages30–30. WILEY 111 RIVER ST, HOBOKEN 07030-5774, NJ USA, 2017.

[10] A. Francis, M. Didsbury, A. Van Zwieten, K. Chen, L. James, S. Kim, K. Howard, G. Williams,S. McTaggart, A. Walker, et al. The impact of chronic kidney disease (ckd) on the quality of lifeof children and adolescents. In NEPHROLOGY, volume 22, pages 12–12. WILEY 111 RIVER ST,HOBOKEN 07030-5774, NJ USA, 2017.

[11] M. F. Lobo, V. Azzone, L. F. Azevedo, B. Melica, A. Freitas, L. Bacelar-Nicolau, F. N. Rocha-Goncalves, C. Nisa, A. Teixeira-Pinto, J. Pereira-Miguel, et al. A comparison of in-hospital acutemyocardial infarction management between portugal and the united states: 2000–2010. Interna-tional Journal for Quality in Health Care, 29(5):669–678, 2017.

[12] M. Lobo, V. Azzone, F. Lopes, A. Freitas, A. Costa-Pereira, S. Normand, and A. Teixeira-Pinto.Between-hospital variation of in-hospital mortality and 30-day readmissions in acute myocardialinfarction in portugal: 2012-2014. Value in Health, 20(9):A496, 2017.

[13] V. Saglimbene, G. Wong, N. Bondonno, M. Ruospo, S. Palmer, K. Campbell, V. G. Larsen, P. Natale,A. Teixeira-Pinto, L. Gargano, et al. Fruit intake and cardiovascular and all-cause mortality inadults on hemodialysis: the diet-hd multinational cohort study. 2017.

[14] V. Saglimbene, G. Wong, M. Ruospo, S. Palmer, K. Campbell, V. G. Larsen, P. Natale, A. Teixeira-Pinto, J. Carrero, P. Stenvinkel, et al. Dietary n-3 and n-6 polyunsaturated fatty acid intake andrisk of mortality in people on hemodialysis: the diet-hd multinational cohort study. 2017.

[15] J. Hywood, A. Teixeira-Pinto, K. Nasserinejad, E. McCusker, and C. Loy. I14 predicting individualdisease progression in huntington’s disease using mixed models and transition models, 2016.

[16] M. Lobo, V. Azzone, B. Melica, L. Bacelar-Nicolau, C. Nisa, A. Freitas, L. Azevedo, F. Rocha-Goncalves, F. Resnic, A. Teixeira-Pinto, et al. The atlantic divide in coronary heart disease: Healthtechnologies use in the us and portugal. Value in health: the journal of the International Society forPharmacoeconomics and Outcomes Research, 18(7):A402, 2015.

[17] M. F. Lobo, V. Azzone, L. Azevedo, A. Teixeira-Pinto, J. P. Miguel, A. Costa-Pereira, F. Resnic, andS. Normand. A comparison of in-hospital acute myocardial infarction management between por-tugal and the united states: 2000-2010. Circulation: Cardiovascular Quality and Outcomes, 7(Suppl1):A123–A123, 2014.

[18] M. F. Lobo, V. Azzone, B. Melica, A. Freitas, F. R. Goncalves, A. J. Soares, S. Normand, A. Teixeira-Pinto, J. Pereira-Miguel, and A. Costa-Pereira. Comparison of the healthcare systems of the unitedstates and portugal: Epidemiology and management of coronary heart disease. Circulation: Car-diovascular Quality and Outcomes, 7(Suppl 1):A367–A367, 2014.

[19] S. Palmer, A. Teixeira-Pinto, V. Saglimbene, P. Macaskill, J. Craig, and G. Strippoli. Associationof surrogate endpoints (serum parathyroid hormone, calcium and phosphorus) with mortality inchronic kidney disease trials: A meta-analysis. In NEPHROLOGY DIALYSIS TRANSPLANTA-TION, volume 29, pages 390–391. OXFORD UNIV PRESS GREAT CLARENDON ST, OXFORDOX2 6DP, ENGLAND, 2014.

[20] P. P. Rodrigues, C. C. Dias, D. Rocha, I. Boldt, A. Teixeira-Pinto, and R. Cruz-Correia. Predictingvisualization of hospital clinical reports using survival analysis of access logs from a virtual pa-tient record. Porceedings of the IEEE 26th International Symposium Computer-Based Medical Systems(CBMS), pages 461–464, 2013.

[21] P. Bartolucci, C. Brugnara, A. Teixeira-Pinto, S. Pissard, K. Moradkhani, H. Jouault, C. Prehu,and F. Galacteros. Les atteintes renales, les ulceres cutanes et le priapisme sont associes a unpourcentage eleve de globules rouges denses au cours de la drepanocytose. La Revue de MedecineInterne, 33:S60–S61, 2012.

[22] A. Ferreira, M. C. Mauricio, L. F. Azevedo, A. Teixeira-Pinto, and N. Sousa. Efficacy of continu-ing zoledronic acid beyond 24 months in metastatic prostate cancer. Journal of Clinical Oncology,29(15), 2011.

[23] P. Povoa, A. Teixeira-Pinto, and A. Carneiro. C-reactive protein as an early marker of sepsisresolution. Critical Care, 15(Suppl 1):P272, 2011.

[24] F. Rocha-Goncalves, B. Marques, A. Teixeira-Pinto, and A. Freitas. An application of the vladmethodology to portuguese hospitals–the case of pneumonia admissions. Livro de resumos da 12o

Conferencia Nacional de Economia da Saude, 2011.

[25] N. Cortesao, C. Granja, and A. Teixeira-Pinto. The piro concept: predisposing conditions forcommunity-squired severe sepsis and septic shock related mortality. Intensive care medicine,36:S288–S288, 2010.

[26] N. Cortesao, A. Pinto, and C. Granja. The piro concept: infection-associated conditions forcommunity-acquired severe sepsis and septic shock related-mortality (results from the saciucistudy). Critical Care Medicine, 38(12):U193–U193, 2010.

[27] P. Povoa, A. Carneiro, and A. Teixeira-Pinto. Patterns of c-reactive protein response to antibiotictherapy in septic patients. results from the portuguese community-acquired sepsis study (saciucistudy). American Journal of Respiratory and Critical Care Medicine, 181:A1136, 2010.

[28] F. Trigo, C. Guimaraes, A. Bodas, A. Teixeira-Pinto, and J. E. Guimaraes. Serum free light chainassessment in 311 patients with gammopathy. Blood, 110(11):260B–261B, 2007.

[29] C. Costa-Santos, A. Teixeira-Pinto, and A. Costa-Pereira. Webbased learning at the faculty ofmedicine of oporto: Description and evaluation of a student’s internet. Proceedings of the 8thInternational Conference of European University Information Systems, pages 152–4, 2002.

[30] S. C. Guerra, J. C. Ribeiro, A. Teixeira-Pinto, J. A. Duarte, and J. A. Mota. Relation between obesityand cardiovascular risk factors in portuguese children. Medicine & Science in Sports & Exercise,34(5):S283, 2002.

[31] J. C. Ribeiro, S. C. Guerra, A. Teixeira-Pinto, J. A. Duarte, and J. A. Mota. Body mass index,physical activity and cardiorespiratory fitness in portuguese children. Medicine & Science in Sports& Exercise, 34(5):S283, 2002.

[32] J. A. Paiva, J. Pereira, C. Sousa-Dias, A. Bodas, A. Teixeira-Pinto, T. Ribeiro, and J. Duarte. Areserum cytokines and adhesion molecules levels useful for severity and risk stratification in sirs-trauma? Intensive Care Medicine, 27:S198–S198, 2001.

[33] J. Ribeiro, S. Guerra, A. Pinto, J. Duarte, and J. Mota. Prevalence in overweight and obesity in aportuguese population of school children, according to the new standard definitions of the bodymass index. Obesity Research, 9:184S–184S, 2001.

[34] H. Antunes, S. Goncalves, A. Teixeira-Pinto, and A. Costa-Pereira. Does the effect of iron defi-ciency anaemia on development revert with iron therapy? Journal of Pediatric Gastroenterology andNutrition, 28(5):586, 1999.

[35] S. Sampaio, A. Teixeira-Pinto, and A. Costa-Pereira. Introducing information technologies on anew course at the faculty of medicine of the oporto university - a short description and analysis.Proceedings of the Global Chinese conferenceon computers in education - GCCCE’99, pages 612–616,1999.

[36] A. Teixeira-Pinto. First year medical students approach to computer assisted learning in terms ofresources access and informatics skills. Proceedings of the Global Chinese conference on computers ineducation - GCCCE’99, pages 24–27, 1999.

[37] M. E. Macedo, A. T. Pinto, A. Pereira, and de A. F. Freitas. Hypertension predicted by tracking ofelevated blood pressure from childhood to adulthood. Journal of the American College of Cardiology,31:481, 1998.

[38] M. E. Macedo, A. T. Pinto, A. Pereira, and A. F. Freitas. Clustering and 17 years clustering-tracking of high blood pressure, overweight and obesity in children and young adults. Journal ofHypertension, 16:S197–S197, 1998.

[39] M. Macedo, A. T. Pinto, M. Pizarro, C. Marujo, A. Pereira, and A. F. Freitas. Evolution of familialaggregation of blood pressure over 17 years in children and young adults. Journal of Hypertension,16(7):1062–1062, 1998.

[40] M. Macedo, A. Teixeira Pinto, C. Marujo, A. Pereira, and Falcao de A. Freitas. Body mass indexand blood pressure in a portuguese population. a longitudinal study. American Journal of Hyper-tension, 11(4):223A, 1998.

[41] M. Macedo, A. Teixeira-Pinto, A. Pereira, and A. Freitas. Evolution of familial aggregation ofblood pressure over 17 years in children and young adults. American Journal of Hypertension,11(4):223A, 1998.

[42] M. Macedo, A. Teixeira-Pinto, M. Pizarro, A. Pereira, and A. Freitas. Value of childhood bloodpressure measurements in predicting future adult elevated blood pressure. American Journal ofHypertension, 11(4):222A, 1998.

[43] J. Paiva, C. Sousa-Dias, A. Bodas, A. Teixeira-Pinto, K. Candeias, and A. Costa-Pereira. Cytokineslevels in neutropenic fever: do they help in risk stratification? Supportive Care in Cancer, (3):79,1998.

[44] A. Teixeira-Pinto, A. Ferreira, P. G, and A. Costa-Pereira. Medical statistics in the web - an onlinemanual for studentsmand health researchers. Actas da 1o Conferencia sobre redes de computadores,pages 9–10, 1998.

[45] M. Macedo, K. Almeida, L. MJ, L. Lopes, A. Teixeira-Pinto, A. Costa-Pereira, and A. Freitas. Alongitudinal study of blood pressure and obesity in children and adolescents. American Journal ofHypertension, 10:200A, 1997.

[46] M. Macedo, M. Lima, J. Castro, M. Pizarro, L. Lopes, A. Teixeira-Pinto, M. Trigueiros, and A. Fre-itas. Predictors for the development of essential hypertension. long-term follow-up study in por-tuguese children. American Journal of Hypertension, 10:200A, 1997.

[47] M. Macedo, M. Trigueiros, A. Flores, A. Duarte, L. Lopes, P. M, and A. Teixeira-Pinto. Trend ofelevated blood pressure from childhood to adulthood over a 17-year period. can essential hyper-tension be predicted. The Canadian Journal of Cardiology, 13:S90B, 1997.

INVITEDPRESENTATIONS

• Recycling GWAS studies: a case for Mendelian Randomisation. Annual Conference of the Interna-tional Society for Clinical Biostatistics. Krakow. Poland. Aug 2020.

• The use of propensity score in health research. University of Dresden, Germany. Jul 2020.• Joint latent class survival and longitudinal models. University of Adelaide. Adelaide Set 2018.• Latent class models for the joint modelling survival and longitudinal data. University of Sydney.

Sydney Oct 2018.• Causal inference with instrumental variables. Macquarie University. Sydney Oct 2016.• Mendelian randomisation. BeatCKD Research Forum. Sydney 31st Aug - 1st Sep 2016.• Using longitudinal biomarkers in prognostic models. University of New South Wales. Sydney 19th

Jun 2015• Key concepts in Medical Statistics. The University of Sydney. Sydney 16th Nov 2013• Development of a Staging System for patients with infection based on the PICO concept. George

Institute. Sydney 18th Apr 2013• CRP as a biomarker for sepsis - a longitudinal approach. Westmead Hospital. Sydney, Mar 2013• Longitudinal evaluation of biomarkers as prognostic factors in SEPSIS. Seminars Series on Probability

and Statistics from the Universidade Tcnica de Lisboa, Lisboa 14th Apr 2011• Interpreting Hazard Ratios. Seminar series on research methods of the Oncologic Institute of Porto,

Portugal Jun 2011• Interpretation of Results in Scientific Studies. Spring Meeting of the Lung Cancer Study Group, Braga

9th Apr 2011• Statistical Inference. Universidade Privada de Angola, Lubango (Angola) Oct 2010• How many patients should I include in my study? Seminar series on research methods of the Onco-

logic Institute of Porto, Portugal Jun 2010• Latent Variable Models in Health Research. Workshop StaM2010: Statistical Modelling - Challenges in

Health, Lisbon 9th-12th May 2010• Regression methods for mixed outcomes. Seminar Series of new PhDs in Statistics. Portuguese Statis-

tical Society. Lisboa, 30th Jan 2008• Analysis of Non-commensurate Outcomes. Academy Health’07, Orlando, Florida, USA June 3rd-5th

Jun 2007• Latent Variable Models for Multiple Non-Commensurate Outcomes, ENAR, Tampa, Florida, USA

26th-29th Mar 2006• Statistical Inference for Non-Commensurate Multiple Source Outcomes, Psychiatric Seminar Series,

Harvard School of Public Health, Boston, USA, Feb 2004

TEACHINGEXPERIENCE

I have more than 20 years of experience teaching basic and advanced statistical courses for undergrad-uate and graduate students, as well as Health professionals seeking competence in data analysis. Formany of these courses I was the main developer of the syllabus and the pedagogic material. I wasan early adopter of technology to support the learning process and interested in its added-value asa pedagogic tool. In 1997, I developed a Web based manual on introductory Biostatistics for Healthprofessionals (http://stat.med.up.pt) and I conducted some small studies evaluating the use of com-puter assisted learning in my own teaching and my Pedagogic Report (Provas de aptidao pedagogica ecapacidade cientıfica) described an online lecture on linear regression.

Below, I enumerate my recent experience in Australia and the main courses I developed and taughtduring my academic career. In this list, I do not include the long list of short courses (typically, 3-4days) on basic Statistics, regression methods, survival analysis, systematic reviews, sample size andpower analysis, clinical trials, and research methods, offered during summer schools, conferences,

professional development courses or to professional associations.

• Machine Learning for Biostatistics - BSTA5018.Masters of Biostatistics. Faculty of Medicine and Health, University of Sydney. 2020No. students per session: 30 thruDeveloper and Lecturer 2021

• Introductory Biostatistics - PUBH5018.Masters of Biostatistics. Faculty of Medicine and Health, University of Sydney. 2021No. students per session: 500co=Developer and Lecturer

• Advanced Statistical Modelling - CEPI5310.Masters of Clinical Epidemiology. Faculty of Medicine, University of Sydney. 2019No. students per session: 26Developer and Lecturer

• Principles of Statistical Inference - BSTA5002.Masters of Biostatistics. Faculty of Medicine, University of Sydney. 2019No. students per session:Developer and Lecturer

• Health Indicators and Health Surveys - BSTA5003.Masters of Biostatistics. Faculty of Medicine, University of Sydney. 2015No. students per session: 30 thruDeveloper and Lecturer 2018

• Biostatistics for the unit of study Project Development - MDMP5225 MD. 2014Medical Students. Faculty of Medicine, University of Sydney. thruAverage no. students per session (4h lectures + 3 workshops): 350 presentDeveloper and Lecturer

• Meta-regression for the Advance Systematic Reviews’ course - CEPI5204.Faculty of Medicine, University of Sydney. Oct 2014Nb. students (Lecture + Lab session): 8Co-Developer and Lecturer

• 5-day immersion Workshop, part of the Principles and Practice of Clinical Research courseTH Chan School of Public Health. Harvard University . Oct 2016Nb. students (16h Lectures/Lab sessions): 35 thruResponsible for the Biostatistics module present

• Introductory Biostatistics - PUBH5018. Lab session for Master of Public 2013Health. School of Public Health, University of Sydney. thruNb. students: 15 presentTutor

• Biostatistics I (Descriptive methods and statistical inference). 2007Course offered to the Doctoral Program in Clinical thruand Health Services Research, 7 ECTS (credits). Faculty of Medicine, 2011University of Porto. Average no. students per edition: 18Course Developer and Instructor

• Biostatistics II. Course offered to the Doctoral Program in Clinical 2007and Health Services Research, 5 ECTS (credits). Faculty of Medicine, thruUniversity of Porto. Average no. students per edition: 16 PresentCourse Developer and Instructor

• Medical Statistics. Course offered to the Doctoral Program in Medicine, 36h. Science 2008Institute Gulbenkian, University Nova de Lisboa. Average no. students per edition: 10 thruCourse Developer and Instructor 2011

• Meta-Analysis. Course offered to the Doctoral Program in Psychology, 16h. 2009Faculty of Psychology, University of Porto. Average no. students per edition: 30 thruCourse co-Developer and co-Instructor 2011

• Introduction to Medicine I (Research Methodology). One semester course offered 2006to the Medical Degree, 5 ECTS (credits). Faculty of Medicine, University of Porto. thruAverage no. of students per edition: 290 2011Course co-Developer and co-Instructor

• Introduction to Medicine II (Biostatistics and Medical Informatics). One semester 2006course offered to the Medical Degree, 5 ECTS (credits). Faculty of Medicine, thruUniversity of Porto. Average no. of students per edition: 290 2012Course co-Developer and co-Instructor

• Biostatistics II. One semester course offered to the Masters on Decision Making 2007in Health, 5 ECTS (credits). Faculty of Medicine, University of Porto. Average no. 2009students per edition: 22 Course Developer and Instructor

• Principles of Clinical Trials. Half semester course offered to MPH/MSc students. 2006Harvard School of Public Health. no. students: 30.Teaching Assistant

• Introduction to Programming in SAS. Half semester course offered to MPH students. 2005Harvard School of Public Health. no. students: 40.Teaching Assistant

• Introduction to Medicine (Research Methodology and Biostatistics). Two semester 1997course offered to the Medical Degree, 12 ECTS (credits). Faculty of Medicine, thruUniversity of Porto. Average no. of students per edition: 180. 2001Te aching Assistant

• Biostatistics. One semester course offered to the Masters program in Oral Health. 1997Faculty of Dentistry, University of Porto. no. of students: 10.Teaching Assistant

• Statistics and Informatics in Health Sciences. One semester course offered to the Masters 1997in Health Economics. Faculty of Medicine, University of Porto. Average no. 1998of students per edition: 10.Teaching Assistant

• Experiments, Validation, and Data Analysis. One semester course offered to the Masters 1998program in Biomedical Engineering. Faculty of Engineering, University of Porto.no. of students: 15.Teaching Assistant

• Statistics and Informatics. One semester course offered to the Masters program in 1998Occupational Medicine. Faculty of Medicine, University of Porto. thruAverage no. of students per session: 15. 2000Teaching Assistant

• Epidemiology. One semester course offered to the Masters program in 1998Occupational Medicine. Faculty of Medicine, University of Porto. thruAverage no. of students per session: 15. 2000Teaching Assistant

• Epidemiology. One semester course offered to the Masters in Health Economics. 1997Faculty of Medicine, University of Porto. Average no. 1998of students per edition: 10.Teaching Assistant

MENTORING Doctoral and Masters Students• Vanessa Kumar. Work Place Project for the Masters of Biostatistics - BCA. Supervisor. 2020

Project title: Effect of Smoking Cessation after Cancer Diagnosis on Survival• Duncan Jomes. Work Place Project for the Masters of Biostatistics - BCA. Supervisor. 2020

Project title: Longitudinal Biomarker Modelling in Adult End-stage Kidney Disease.• Lena Lim, MPhil student Supervisor. 2024 (expected)

Dissertation tittle: Real-world glycaemic data before and after commencementof continuous glucose monitoring among a Paediatric Diabetes cohort

• Tess Cooper, PhD student Auxilary Supervisor. 2022 (expected)Dissertation tittle: Understanding the interplay between the gut-kydney axis inpeolple with chronic kidney disease

• Anoushka Krishnan. MPhil student. University of Sydney.Supervisor. 2020 (expected)Dissertation tittle: Gastrointestinal complications in patients with chronic kidneydisease: identifying risk factors, cancer screening, quality of life and outcomes

• Simon Carter. PhD. University of Sydney. Supervisor. 2021 (expected)Dissertation title:Developing a standardised set of core outcomes forglomerulonephritis: SONG-GN.

• Eric Au. PhD student. University of Sydney. Co-supervisor. 2021 (expected)Dissertation title: Improving outcomes in patients with chronic kidney disease.

• Nick Larkins. PhD student. University of Sydney. Co-supervisor. 2018Dissertation title: Kidney Disease among Indigenous Australians

• Emma Liu. MPhil student. University of Sydney. Supervisor. 2019Dissertation title: Osteocalcin levels in patients with type 2 diabetes.

• Silvia Panunzi. MSc student. University of Zurich. Supervisor. 2018Dissertation title: Join modelling of longitudinal and survival data using arandom survival Forest.

• Jorge Almeida dos Reis. Doctoral program in Clinical and Health Services 2018 (suspension)Research. University of Porto. Co-supervisor. Dissertation title: Incidenceand predictive factors of memory loss after anaesthesia in extracorporealshockwave myocardial revascularisation.

• Mariana Lobo. Doctoral program in Clinical and Health Services Research. 2018University of Porto. Supervisor. Dissertation title: Comparative analysisbetween the health care systems of the United States (US) and Portugal (PT): Accessand effectiveness of coronary heart disease (CHD) treatment.

• Fei He. Doctoral Program in Biostatistics. Indiana University. Co-supervisor. 2016Dissertation title: Cross-lagged models based on non-commensurate outcomeswith consistent or inconsistent time intervals.

• Minh-Son To. Work Place Project for the Masters of Biostatistics - BCA. 2017University of Sydney. Supervisor. Project title: haemodynamic response to fluidbolus therapy (fluid administered in under 30 minutes) in post cardiac surgery patients.

• Shehani Tissera. Work Place Project for the Masters of Biostatistics - BCA. 2015University of Sydney. Supervisor. Project title: Prevalence of helminthiasis among schoolchildren in the north of Guinea- Bissau (West Africa) and its associationwith living conditions, habits, attitudes and knowledge.

• Cristina Lobo. Master in Statistics. University of Minho. Supervisor. Dissertation 2012title: Development of a Statistical Model for Sepsis.

• Jorge Jacome Gomes. Master in Medical Informatics. University of Porto. 2010Co-supervisor Dissertation title: MedQuest Web-based health questionnaires in the Web

Junior ResearchersI supervised the following Research Assistants:

• Michael Hugh Connors, Medical Student, Research Project on Huntington’s Disease. 2016• Minghao Wu and Natalie Trinh. Undergraduate students of Statistics. Computer

coding for multiple research projects. 2015• Jack Hywood, Medical Student, Research Project on Huntington’s Disease. 2014• Sara Wang, Medical Student, Research Project on Huntington’s Disease. 2014• Luis Pinto, 1 yr Research Fellowship (National Foundation for Science and 2009

Technology BII/UNI/0753/SAU/2009)• Rosa Celeste Santos Oliveira, 2 yrs Research Fellowship (National Foundation 2008 - 2010

for Science and Technology PTDC/SAL-ESA/100841/2008).• Ana Cristina Ferreira de Sousa Lobo, 3 yrs Research Fellowship (National 2007 - 2010

Foundation for Science and Technology PIC/IC/83312/2007).• Claudia Camila Dias, Consultant Statistician. 2007 - 2012• Orquidea Ribeiro, Consultant Statistician. 2007 - 2012• Filipe Azevedo, Medical Student. Research project: Diet and gastric cancer in Portugal. 1998

EDITORIALBOARDS

• Statistical advisor for Cochrane Kidney and Transplant. Since Aug 2017• Senior Statistical Editor. Journal of Circulation: Cardiovascular Since Aug 2016

Quality and Outcomes.• Editorial Board. Journal of Epidemiologic Methods. Since Aug 2011• Statistical Reviewer. The Lancet and Lancet’s specialty journals (by invitation). Since Dez 2014• Ad-hoc reviewer for: Statistics in Medicine, Statistical Method in Medical Research, Circulation, Philo-

sophicalTransactions of the Royal Society A, Critical Care Medicine, Medical Decision Making, Health Services

and OutcomesResearch Methodology, American Journal of Hematology, Plos One, BMC Medical ResearchMethodology, Acta Medica, The Breast

• Associate Statistical Editor. Journal of Circulation: Cardiovascular Aug 2010 - Aug 2016Quality and Outcomes.

ACADEMICSERVICE

Committees• Member of the Head of School Advisory Board, School of Public Health Since 2020• Academic Board School of Public Health Since 2019• Academic Leader Research Education (Postgraduate Coordinator of the high

degree by research committee), School of Public Health, The University of Sydney 2019-2020• Deputy Postgraduate Coordinator of the high degree by research committee 2017-2018• Beat-CKD Operations Committee (program grant) Since May 2016• Member of the Public Health Management Advisory Committee, School of 2014 -2016

Public Health, University of Sydney.• Councillor of the NSW brach of the Statistical Society of Australian Inc. 2013 - 2017• Member of the Public Health Management Advisory Committee, School of 2014 -2014

Public Health, University of Sydney.• Academic Panel of the Annual Progress Interviews, School of Public Health, 2014 - 2015

University of Sydney• Reviewer of a research proposal submitted to The Israel Science Foundation Mar 2014• Reviewer of a grant application for the Swiss National Science Foundation Aug 2013• Scientific Committee of the Masters on Decision Making 2008-2012

in Health and Medicine, Faculty of Medicine, University of Porto, Portugal.• Member of the University Senate, University of Porto, Portugal. 2001• Member of the Assembleia de Representantes, Faculty of Medicine, University 2001

of Porto, Portugal.

Thesis examination• Examiner of the MPhil thesis in Statistics by Bethany Phipps, May 2019

with the thesis entitled ”Longitudinal Data Analysis for Improving Patient OutcomesFollowing Hip Replacement Surgery”. University of Adelaide.

• Examiner of the portfolio for the degree of Master of Biostatistics by Ed Lin, May 2019with the thesis entitled ”Kynurenine pathway metabolomics predicts breast cancersubtypes in case-control cohort from Victorian Cancer Biobank”. University of Sydney.

• Examiner of the portfolio for the degree of Master of Biostatistics by Gavin Abbott Nov 2018with the thesis entitled ”Mediators of the effect of the sedentary behaviourintervention in the Transform-Us! trial”. Monash University.as

• Examiner of the portfolio for the degree of Master of Biostatistics by Joseph Hanna. Jul 2018University of Sydney and NSW Ministry of Health.

• Examiner of the portfolio for the degree of Master of Biostatistics by Jacob Humphries. Jul 2018University of Sydney and NSW Ministry of Health.

• Examiner of the MPhil thesis by Ding Ma entitled ”Penalised method of sieves for Dec 2017semi-parametric AFT model with right-censored survival data”, University ofMacquarie, Sydney.

• Examiner of the portfolio for the degree of Master of Biostatistics by Daneeta Hennessy. Jul 2017University of Sydney and NSW Ministry of Health.

• Examiner of the PhD thesis by Annibale Cois entitle ”Understanding hypertension May 2017dynamics in the South African population: a latent variables approach to theanalysis and comparison of data from multiple surveys.”, University of CapeTown, South Africa

• Examiner of the PhD thesis by Md Hamidul Huque entitled ”Spatial Modeling, May 2017Covariate Measurement Error and Design Issues in Environmental Epidemiology”,University of Technology Sydney

• Examiner of the portfolio for the degree of Master of Biostatistics by Richard Hiscock . Dec 2016with the thesis entitled ”The development of calibrated final sample weights forthe Growing Up in Australia Child Health CheckPoint study.”. University of Melbourne.

• Examiner of the portfolio for the degree of Master of Biostatistics by Bradley Drayton. Nov 2016University of Sydney and NSW Ministry of Health.

• Examiner of the portfolio for the degree of Master of Biostatistics by James Totterdell. Nov 2016University of Sydney and NSW Ministry of Health.

• Examiner of the portfolio for the degree of Master of Biostatistics by Sharmala Nov 2015Thuraisingam, with the thesis entitled ”Do more active children sleep more, and is zBMIin adolescence associated with use of time?”. University of Melbourne.

• Examiner of the portfolio for the degree of Master of Biostatistics by Ingrid Stacey Nov 2015with the thesis entitled ”Association between tobacco plain packaging and Quitline

calls: a population-based, interrupted time- series analysis”. University of Sydney.• Examiner of the portfolio for the degree of Master of Biostatistics by Kathrin Schemann. Dec 2015

University of Sydney and NSW Ministry of Health.• Examiner of the portfolio for the degree of Master of Biostatistics by Adam Skinner. Dec 2015

University of Sydney and NSW Ministry of Health.• Examiner of the portfolio for the degree of Master of Biostatistics by Mirjam Kaestli Apr 2014

with the thesis entitled ”The Association of Weather Parameters with the MelioidosisIncidence Rate in the Top End of Australia”. University of Sydney.

• Examiner for the Phd thesis by Cristina Costa Santos entitled ”Statistical Methods for Jun 2010Assessing Agreement of Measurements”. University of Porto. Portuhal.

• Examiner for the Masters degree of Fernanda Felicio, with the thesis entitled Jun 2010”Evaluation of perception of colon and rectal cancer risk for obese patients”.University of Porto.

• Examiner for the Masters degree of Catia Moreira, with the thesis entitled Jul 2010”Evaluation of the Manchester Triage system”. University of Porto.

Scientific meetings• Chair of a session at the conference ICBS 2018, Melbourne,. 2018• Chair of a session at the conference ICBS 2017, Vigo, Spain. 2017• Chair of a session at the workshop BEAT-CKD Research Forum, Adelaide. 2017• Chair of a session at the conference ENAR 2016, Austin, USA. 2016• Chair of ”Models for Multivariate (Longitudinal) Data”, session at JSM, Seattle, USA. 2006• Organising committee of the Workshop ”Health Services Research: from Dec 2014

data to evidence” and session Chair, Lisbon, Portugal.• Promoter and organiser of monthly research meetings for the Biostatistics group Since 2016

at the Sydney School of Public Health.• Organiser of monthly seminars promoted by the STEP group 2014-2016• Organiser committee of ”Some challenging applications of statistical

modelling and analysis: Symposium honouring Professor Arthur Dempster’s 2005retirement”, Harvard University, USA.

• Organiser of the Bayesian Group, Dept. of Biostatistics, Harvard School of 2005Public Health.

• Scientific reviewer for the YES (Young European Scientists) meeting Set 2016• Scientific reviewer for the YES (Young European Scientists) meeting Set 2015• Scientific committee of the 38th Annual Conference of the International Jul 2017

Society for Clinical Biostatistics, Vigo, Spain

Scientific boards• Data and safety monitoring committee. Clinical trial: Efficacy and safety of Tocilizumab 2020

in patients with COVID-19. Multicentre, international trial.• Data and safety monitoring committee. Clinical trial: Optimized tDCS for fibromyalgia: 2020

targeting the endogenous pain control system. Spaulding Rehabilitation Hospital, Boston, USA .• Member of the Australasian Kidney Trials Network (AKTN) Scientific Committee Since Nov 2018

LANGUAGESKILLS

Self assessment - Common European Framework of Reference (CEF) level• Portuguese: Mother tongue• English: Listening C2, Reading C2, Spoken Interaction C2, Spoken Production C1, Writing C2• Spanish: Listening C2, Reading C2, Spoken Interaction C2, Spoken Production C1, Writing B1• French: Listening B1, Reading B1, Spoken Interaction A2, Spoken Production A2, Writing A2